{
  "entities": [
    {
      "id": "E1",
      "type": "Condition",
      "name": "major depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.95,
      "evidence": "Patients with major depression (MDD)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "bipolar disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.95,
      "evidence": "bipolar disorder (BD)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "C-reactive protein",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.9,
      "evidence": "Elevated C-reactive protein (CRP)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "interleukin-6",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.9,
      "evidence": "interleukin-6 (IL-6)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "tumor necrosis factor-alpha",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.9,
      "evidence": "tumor necrosis factor-\\alpha (TNF-\\alpha)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "NF-kappaB",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.85,
      "evidence": "NF-\\kappaB",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "JAK/STAT",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.85,
      "evidence": "JAK/STAT",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "MAPK",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.85,
      "evidence": "MAPK cascades",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "NLRP3 inflammasome",
      "attributes": {
        "target_type": "protein complex"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.8,
      "evidence": "NLRP3 inflammasome",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "BDNF/TrkB signaling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.8,
      "evidence": "BDNF/TrkB signaling",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "kynurenine pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.8,
      "evidence": "kynurenine pathway (KP)",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "low-grade systemic inflammation",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.9,
      "evidence": "low-grade systemic inflammation",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "greater severity",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.8,
      "evidence": "greater severity",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "cognitive impairment",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.85,
      "evidence": "cognitive impairment",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "poor treatment response",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.85,
      "evidence": "poor treatment response",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Effect",
      "name": "excitotoxicity",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.8,
      "evidence": "fostering excitotoxicity",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Effect",
      "name": "synaptic deficits",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.8,
      "evidence": "synaptic deficits",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Effect",
      "name": "poor antidepressant outcomes",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.85,
      "evidence": "predict poor antidepressant outcomes",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Compound",
      "name": "infliximab",
      "attributes": {},
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.9,
      "evidence": "infliximab",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Compound",
      "name": "celecoxib",
      "attributes": {},
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.9,
      "evidence": "celecoxib",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Evidence",
      "name": "translational studies",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.8,
      "evidence": "Translational studies demonstrate",
      "verified": true
    },
    {
      "id": "E22",
      "type": "Study",
      "name": "multi-omics approaches",
      "attributes": {
        "design": "multi-omics"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.75,
      "evidence": "Emerging multi-omics approaches",
      "verified": true
    },
    {
      "id": "E23",
      "type": "Condition",
      "name": "inflammatory biotype of mood disorders",
      "attributes": {
        "condition_type": "subtype"
      },
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "confidence": 0.85,
      "evidence": "inflammatory biotype' of mood disorders",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "major depressive disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "e6b20c74cd831c837a9616dd1927efbe"
      ],
      "confidence": 0.95,
      "evidence": "major depressive disorder (MDD)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "bipolar disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "e6b20c74cd831c837a9616dd1927efbe"
      ],
      "confidence": 0.95,
      "evidence": "bipolar disorder (BD)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "monoaminergic dysfunction",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "e6b20c74cd831c837a9616dd1927efbe"
      ],
      "confidence": 0.85,
      "evidence": "monoaminergic dysfunction model",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "immune\u2013inflammatory dysregulation",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "e6b20c74cd831c837a9616dd1927efbe"
      ],
      "confidence": 0.85,
      "evidence": "immune\u2013inflammatory dysregulation",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "MDD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.9,
      "evidence": "MDD",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "BD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.9,
      "evidence": "BD",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "IL-6",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.95,
      "evidence": "interleukin-6 (IL-6)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "TNF-\u03b1",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.95,
      "evidence": "tumor necrosis factor-\u03b1 (TNF-\u03b1)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "CRP",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.9,
      "evidence": "C-reactive protein (CRP)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "hs-CRP",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.85,
      "evidence": "hs-CRP levels above 3 mg/L",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "gut microbiota",
      "attributes": {
        "target_type": "microbial_community"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.8,
      "evidence": "gut microbiota dysbiosis",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "blood-brain barrier",
      "attributes": {
        "target_type": "barrier"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.85,
      "evidence": "blood\u2013brain barrier (BBB)",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "TLR4",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.9,
      "evidence": "Toll-like receptor 4 (TLR4)",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "NOD1/2",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.85,
      "evidence": "NOD1/2 receptors",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "NF-\u03baB",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.9,
      "evidence": "nuclear factor kappa B (NF-\u03baB)",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "JAK/STAT",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.85,
      "evidence": "Janus kinase/signal transducer and activator of transcription (JAK/STAT)",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "MAPK",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.85,
      "evidence": "mitogen-activated protein kinase (MAPK) pathways",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "NLRP3 inflammasome",
      "attributes": {
        "target_type": "complex"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.85,
      "evidence": "NLRP3 inflammasome",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Target",
      "name": "microglia",
      "attributes": {
        "target_type": "cell_type"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.9,
      "evidence": "microglia",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Target",
      "name": "astrocytes",
      "attributes": {
        "target_type": "cell_type"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.9,
      "evidence": "astrocytes",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Target",
      "name": "BDNF/TrkB",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.85,
      "evidence": "BDNF/TrkB pathways",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Target",
      "name": "kynurenine pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.85,
      "evidence": "kynurenine pathway (KP)",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Target",
      "name": "IDO",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.85,
      "evidence": "indoleamine-2,3-dioxygenase (IDO)",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Target",
      "name": "TDO",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.85,
      "evidence": "tryptophan-2,3-dioxygenase (TDO)",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Compound",
      "name": "quinolinic acid",
      "attributes": {},
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.85,
      "evidence": "quinolinic acid (QA)",
      "verified": true
    },
    {
      "id": "E22",
      "type": "Compound",
      "name": "kynurenic acid",
      "attributes": {},
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.85,
      "evidence": "kynurenic acid (KYNA)",
      "verified": true
    },
    {
      "id": "E23",
      "type": "Effect",
      "name": "low-grade systemic inflammation",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.9,
      "evidence": "low-grade systemic inflammation",
      "verified": true
    },
    {
      "id": "E24",
      "type": "Effect",
      "name": "neuroinflammation",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.85,
      "evidence": "foster neuroinflammation",
      "verified": true
    },
    {
      "id": "E25",
      "type": "Effect",
      "name": "excitotoxicity",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "confidence": 0.8,
      "evidence": "contributing to excitotoxicity",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "NF-\u03baB",
      "attributes": {
        "target_type": "transcription factor"
      },
      "source_chunk_ids": [
        "42702aafa9f078fb65e9c3fd09001322"
      ],
      "confidence": 0.9,
      "evidence": "activation of NF-\u03baB",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "NLRP3",
      "attributes": {
        "target_type": "inflammasome"
      },
      "source_chunk_ids": [
        "42702aafa9f078fb65e9c3fd09001322"
      ],
      "confidence": 0.9,
      "evidence": "NLRP3-dependent cascades",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "mood disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "42702aafa9f078fb65e9c3fd09001322"
      ],
      "confidence": 0.95,
      "evidence": "mood disorders arise",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "MDD",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "42702aafa9f078fb65e9c3fd09001322"
      ],
      "confidence": 0.85,
      "evidence": "susceptibility to MDD",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "BD",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "42702aafa9f078fb65e9c3fd09001322"
      ],
      "confidence": 0.85,
      "evidence": "susceptibility to MDD and BD",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "HPA axis",
      "attributes": {
        "target_type": "neuroendocrine system"
      },
      "source_chunk_ids": [
        "42702aafa9f078fb65e9c3fd09001322"
      ],
      "confidence": 0.8,
      "evidence": "hypothalamic\u2013pituitary\u2013adrenal (HPA) axis",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "hypercortisolemia",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "42702aafa9f078fb65e9c3fd09001322"
      ],
      "confidence": 0.75,
      "evidence": "leading to hypercortisolemia",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "glucocorticoid receptor resistance",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "42702aafa9f078fb65e9c3fd09001322"
      ],
      "confidence": 0.75,
      "evidence": "glucocorticoid receptor resistance",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "sustained low-grade inflammation",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "42702aafa9f078fb65e9c3fd09001322"
      ],
      "confidence": 0.8,
      "evidence": "sustained low-grade inflammation",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "microglial priming",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "42702aafa9f078fb65e9c3fd09001322"
      ],
      "confidence": 0.7,
      "evidence": "persistent microglial priming",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "heightened inflammatory reactivity",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "42702aafa9f078fb65e9c3fd09001322"
      ],
      "confidence": 0.7,
      "evidence": "heightened inflammatory reactivity",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "systemic metabolic inflammation",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "42702aafa9f078fb65e9c3fd09001322"
      ],
      "confidence": 0.75,
      "evidence": "promote systemic metabolic inflammation",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Evidence",
      "name": "systematic review",
      "attributes": {
        "evidence_level": 1
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.8,
      "evidence": "Priority was given to systematic reviews",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "meta-analysis",
      "attributes": {
        "evidence_level": 1
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.8,
      "evidence": "meta-analyses",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Evidence",
      "name": "randomized controlled trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.8,
      "evidence": "randomized controlled trials",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Evidence",
      "name": "cohort study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.7,
      "evidence": "large cohort studies",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "major depressive disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.95,
      "evidence": "\"major depressive disorder\"",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.95,
      "evidence": "\"depression\"",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "bipolar disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.95,
      "evidence": "\"bipolar disorder\"",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "bipolar depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.95,
      "evidence": "\"bipolar depression\"",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "cytokine",
      "attributes": {
        "target_type": "biomarker"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.9,
      "evidence": "\"cytokine\"",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "C-reactive protein",
      "attributes": {
        "target_type": "biomarker"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.9,
      "evidence": "\"C-reactive protein\"",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "IL-6",
      "attributes": {
        "target_type": "biomarker"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.9,
      "evidence": "\"IL-6\"",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "TNF",
      "attributes": {
        "target_type": "biomarker"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.9,
      "evidence": "\"TNF\"",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "neuroinflammation",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.85,
      "evidence": "\"neuroinflammation\"",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "translocator protein",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.85,
      "evidence": "\"translocator protein\"",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Target",
      "name": "kynurenine",
      "attributes": {
        "target_type": "metabolite"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.85,
      "evidence": "\"kynurenine\"",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Target",
      "name": "blood\u2013brain barrier",
      "attributes": {
        "target_type": "structure"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.85,
      "evidence": "\"blood\u2013brain barrier\"",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Target",
      "name": "microbiome",
      "attributes": {
        "target_type": "system"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.85,
      "evidence": "\"microbiome\"",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Target",
      "name": "oxidative stress",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.85,
      "evidence": "\"oxidative stress\"",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Target",
      "name": "mitochondria",
      "attributes": {
        "target_type": "organelle"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.85,
      "evidence": "\"mitochondria\"",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Target",
      "name": "BDNF",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.85,
      "evidence": "\"BDNF\"",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Target",
      "name": "TSPO-PET",
      "attributes": {
        "target_type": "imaging"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.8,
      "evidence": "neuroimaging (TSPO-PET)",
      "verified": true
    },
    {
      "id": "E22",
      "type": "Target",
      "name": "quinolinic acid",
      "attributes": {
        "target_type": "metabolite"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.8,
      "evidence": "quinolinic and kynurenic acid",
      "verified": true
    },
    {
      "id": "E23",
      "type": "Target",
      "name": "kynurenic acid",
      "attributes": {
        "target_type": "metabolite"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.8,
      "evidence": "quinolinic and kynurenic acid",
      "verified": true
    },
    {
      "id": "E24",
      "type": "Target",
      "name": "NLR",
      "attributes": {
        "target_type": "index"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.8,
      "evidence": "NLR, PLR, MLR",
      "verified": true
    },
    {
      "id": "E25",
      "type": "Target",
      "name": "PLR",
      "attributes": {
        "target_type": "index"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.8,
      "evidence": "NLR, PLR, MLR",
      "verified": true
    },
    {
      "id": "E26",
      "type": "Target",
      "name": "MLR",
      "attributes": {
        "target_type": "index"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.8,
      "evidence": "NLR, PLR, MLR",
      "verified": true
    },
    {
      "id": "E27",
      "type": "Target",
      "name": "monocyte subsets",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.8,
      "evidence": "monocyte subsets",
      "verified": true
    },
    {
      "id": "E28",
      "type": "Target",
      "name": "T cells",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.8,
      "evidence": "T cells",
      "verified": true
    },
    {
      "id": "E29",
      "type": "Target",
      "name": "NF-\u03baB",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.8,
      "evidence": "NF-\\kappaB",
      "verified": true
    },
    {
      "id": "E30",
      "type": "Target",
      "name": "JAK/STAT",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.8,
      "evidence": "JAK/STAT",
      "verified": true
    },
    {
      "id": "E31",
      "type": "Target",
      "name": "MAPK",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.8,
      "evidence": "MAPK",
      "verified": true
    },
    {
      "id": "E32",
      "type": "Target",
      "name": "NLRP3",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.8,
      "evidence": "NLRP3",
      "verified": true
    },
    {
      "id": "E33",
      "type": "Target",
      "name": "IL-1\u03b2",
      "attributes": {
        "target_type": "biomarker"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.8,
      "evidence": "IL-1\\beta",
      "verified": true
    },
    {
      "id": "E34",
      "type": "Target",
      "name": "IL-18",
      "attributes": {
        "target_type": "biomarker"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.8,
      "evidence": "IL-18",
      "verified": true
    },
    {
      "id": "E35",
      "type": "Target",
      "name": "glial alterations",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.75,
      "evidence": "glial and astrocytic alterations",
      "verified": true
    },
    {
      "id": "E36",
      "type": "Target",
      "name": "astrocytic alterations",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.75,
      "evidence": "glial and astrocytic alterations",
      "verified": true
    },
    {
      "id": "E37",
      "type": "Target",
      "name": "mitochondrial pathways",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.75,
      "evidence": "mitochondrial and redox pathways",
      "verified": true
    },
    {
      "id": "E38",
      "type": "Target",
      "name": "redox pathways",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.75,
      "evidence": "mitochondrial and redox pathways",
      "verified": true
    },
    {
      "id": "E39",
      "type": "Target",
      "name": "synaptic plasticity",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.75,
      "evidence": "synaptic plasticity",
      "verified": true
    },
    {
      "id": "E40",
      "type": "Target",
      "name": "gut\u2013brain axis",
      "attributes": {
        "target_type": "system"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.75,
      "evidence": "gut\u2013brain axis",
      "verified": true
    },
    {
      "id": "E41",
      "type": "Target",
      "name": "BBB markers",
      "attributes": {
        "target_type": "marker"
      },
      "source_chunk_ids": [
        "82c64ce2567d3a2e2d6de45a1e5ca256"
      ],
      "confidence": 0.75,
      "evidence": "BBB markers",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "peripheral immune activation",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "e41a1d643678bd30f5fb493982c34a70"
      ],
      "confidence": 0.8,
      "evidence": "peripheral immune activation",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "central neuroinflammation",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "e41a1d643678bd30f5fb493982c34a70"
      ],
      "confidence": 0.8,
      "evidence": "central neuroinflammation",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "mood disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "e41a1d643678bd30f5fb493982c34a70"
      ],
      "confidence": 0.9,
      "evidence": "mood disorders",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "gut dysbiosis",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "e41a1d643678bd30f5fb493982c34a70"
      ],
      "confidence": 0.75,
      "evidence": "gut dysbiosis",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "barrier permeability",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "e41a1d643678bd30f5fb493982c34a70"
      ],
      "confidence": 0.75,
      "evidence": "barrier permeability",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "immune activation",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "e41a1d643678bd30f5fb493982c34a70"
      ],
      "confidence": 0.75,
      "evidence": "immune activation",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "neuroinflammatory changes",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "e41a1d643678bd30f5fb493982c34a70"
      ],
      "confidence": 0.75,
      "evidence": "neuroinflammatory changes",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PERIPHERAL IMMUNE ACTIVATION",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.9,
      "evidence": "PERIPHERAL IMMUNE ACTIVATION",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "Blood brain barrier",
      "attributes": {
        "target_type": "structure"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.9,
      "evidence": "Blood brain barrier",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "CENTRAL NEUROINFLAMMATION",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.9,
      "evidence": "CENTRAL NEUROINFLAMMATION",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "macrophages",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.85,
      "evidence": "macrophages",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "neutrophils",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.85,
      "evidence": "neutrophils",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "T-lymphocytes",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.85,
      "evidence": "T-lymphocytes",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "B-lymphocytes",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.85,
      "evidence": "B-lymphocytes",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "TNF-\u03b1",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.9,
      "evidence": "TNF-\u03b1",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "IL-6",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.9,
      "evidence": "IL-6",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "IL-1\u03b2",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.9,
      "evidence": "IL-1\u03b2",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "MCP-1",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.9,
      "evidence": "MCP-1",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "CRP",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.85,
      "evidence": "CRP",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "ROS",
      "attributes": {
        "target_type": "species"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.8,
      "evidence": "ROS (reactive oxygen species)",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "microglia",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.85,
      "evidence": "microglia",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Target",
      "name": "astrocytes",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.85,
      "evidence": "astrocytes",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Target",
      "name": "glutamate clearance",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.8,
      "evidence": "glutamate clearance",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Condition",
      "name": "FATIGUE",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.9,
      "evidence": "FATIGUE",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Condition",
      "name": "PSYCHOMOTOR SLOWING",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.9,
      "evidence": "PSYCHOMOTOR SLOWING",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Condition",
      "name": "ANHEDONIA",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.9,
      "evidence": "ANHEDONIA",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Condition",
      "name": "COGNITIVE IMPAIRMENT",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.9,
      "evidence": "COGNITIVE IMPAIRMENT",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Condition",
      "name": "mood disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "confidence": 0.8,
      "evidence": "mood disorders",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "BBB",
      "attributes": {
        "target_type": "biological barrier"
      },
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "confidence": 0.9,
      "evidence": "influence the BBB",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "tight junction proteins",
      "attributes": {
        "target_type": "protein complex"
      },
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "confidence": 0.85,
      "evidence": "disrupt tight junction proteins",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "occludin",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "confidence": 0.8,
      "evidence": "including occludin",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "claudin-5",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "confidence": 0.8,
      "evidence": "and claudin-5",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "TNF-alpha",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "confidence": 0.85,
      "evidence": "TNF-alpha",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "IL-6",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "confidence": 0.85,
      "evidence": "IL-6",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "ROS",
      "attributes": {
        "target_type": "reactive species"
      },
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "confidence": 0.8,
      "evidence": "ROS",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "glial cells",
      "attributes": {
        "target_type": "cell type"
      },
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "confidence": 0.8,
      "evidence": "activate glial cells",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "BBB dysfunction",
      "attributes": {
        "condition_type": "pathological state"
      },
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "confidence": 0.9,
      "evidence": "BBB dysfunction in mood disorders",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "MDD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "confidence": 0.85,
      "evidence": "MDD",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "BD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "confidence": 0.85,
      "evidence": "BD",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "S100B",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "confidence": 0.85,
      "evidence": "serum S100B",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "increased permeability",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "confidence": 0.85,
      "evidence": "leading to increased permeability",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "neuroinflammation",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "confidence": 0.85,
      "evidence": "foster neuroinflammation",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "gut dysbiosis",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.95,
      "evidence": "Gut dysbiosis with reduced microbial diversity",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "neuroinflammation",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.95,
      "evidence": "drive neuroinflammation in depression",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.9,
      "evidence": "neuroinflammation in depression",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "gut barrier integrity",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.85,
      "evidence": "impaired gut barrier integrity",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "blood-brain barrier",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.85,
      "evidence": "disrupt the BBB",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "microglia",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.9,
      "evidence": "activate microglia",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "astrocytes",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.8,
      "evidence": "activate microglia and astrocytes",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "monocytes",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.9,
      "evidence": "activate monocytes",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "inflammation",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.9,
      "evidence": "Systemic inflammation",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "cytokine production",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.85,
      "evidence": "monocytes produce cytokines",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "LPS",
      "attributes": {},
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.9,
      "evidence": "lipopolysaccharides (LPS)",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Compound",
      "name": "PGN",
      "attributes": {},
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.85,
      "evidence": "peptidoglycan (PGN)",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Compound",
      "name": "TMAO",
      "attributes": {},
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.85,
      "evidence": "trimethylamine-N-oxide (TMAO)",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Compound",
      "name": "flagellin",
      "attributes": {},
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.8,
      "evidence": "flagellin",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Compound",
      "name": "SCFA",
      "attributes": {},
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.85,
      "evidence": "short-chain fatty acid (SCFA)",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Compound",
      "name": "IL-6",
      "attributes": {},
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.8,
      "evidence": "cytokines (IL-6, TNF-\u03b1, IL-1\u03b2)",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Compound",
      "name": "TNF-\u03b1",
      "attributes": {},
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.8,
      "evidence": "cytokines (IL-6, TNF-\u03b1, IL-1\u03b2)",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Compound",
      "name": "IL-1\u03b2",
      "attributes": {},
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.8,
      "evidence": "cytokines (IL-6, TNF-\u03b1, IL-1\u03b2)",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Target",
      "name": "Oscillibacter",
      "attributes": {
        "target_type": "bacteria"
      },
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.75,
      "evidence": "Oscillibacter (red rod)",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Target",
      "name": "Alistipes",
      "attributes": {
        "target_type": "bacteria"
      },
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.75,
      "evidence": "Alistipes (pink rod)",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Target",
      "name": "Faecalibacterium",
      "attributes": {
        "target_type": "bacteria"
      },
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.75,
      "evidence": "Faecalibacterium (purple rod)",
      "verified": true
    },
    {
      "id": "E22",
      "type": "Target",
      "name": "Roseburia",
      "attributes": {
        "target_type": "bacteria"
      },
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "confidence": 0.75,
      "evidence": "Roseburia (green rod)",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "pattern-recognition receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "f3afbb81afdf28e84adf4bf7d2c9c86d"
      ],
      "confidence": 0.9,
      "evidence": "pattern-recognition receptors (PRRs)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "Toll-like receptor 4",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "f3afbb81afdf28e84adf4bf7d2c9c86d"
      ],
      "confidence": 0.95,
      "evidence": "Toll-like receptor 4 (TLR4)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "lipopolysaccharides",
      "attributes": {
        "target_type": "molecular pattern"
      },
      "source_chunk_ids": [
        "f3afbb81afdf28e84adf4bf7d2c9c86d"
      ],
      "confidence": 0.85,
      "evidence": "lipopolysaccharides (LPS)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "HMGB1",
      "attributes": {
        "target_type": "molecular pattern"
      },
      "source_chunk_ids": [
        "f3afbb81afdf28e84adf4bf7d2c9c86d"
      ],
      "confidence": 0.8,
      "evidence": "HMGB1",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "extracellular ATP",
      "attributes": {
        "target_type": "molecular pattern"
      },
      "source_chunk_ids": [
        "f3afbb81afdf28e84adf4bf7d2c9c86d"
      ],
      "confidence": 0.8,
      "evidence": "extracellular ATP",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "TLR4",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "confidence": 0.95,
      "evidence": "Engagement of TLR4",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "NF-\u03baB",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "confidence": 0.95,
      "evidence": "NF-\u03baB",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "JAK/STAT",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "confidence": 0.95,
      "evidence": "JAK/STAT",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "MAPK",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "confidence": 0.95,
      "evidence": "MAPK pathways",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "cytokine receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "confidence": 0.85,
      "evidence": "cytokine receptors",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "IL-6",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "confidence": 0.9,
      "evidence": "IL-6",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "TNF-\u03b1",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "confidence": 0.9,
      "evidence": "TNF-\u03b1",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "IL-1\u03b2",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "confidence": 0.9,
      "evidence": "IL-1\u03b2",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "mood disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "confidence": 0.9,
      "evidence": "mood disorders",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "growing evidence",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "confidence": 0.7,
      "evidence": "growing evidence implicating",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "NF-\u03baB",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "confidence": 0.95,
      "evidence": "NF-\u03baB activation in the hippocampus",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "stress-induced suppression of neurogenesis",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "confidence": 0.85,
      "evidence": "stress-induced suppression of neurogenesis",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "depressive-like behavior",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "confidence": 0.9,
      "evidence": "depressive-like behavior",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "MDD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "confidence": 0.95,
      "evidence": "patients with MDD",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "IL-6/STAT3 signaling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "confidence": 0.9,
      "evidence": "Persistent IL-6/STAT3 signaling",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "impaired neuroplasticity",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "confidence": 0.85,
      "evidence": "impaired neuroplasticity",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "MAPK",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "confidence": 0.9,
      "evidence": "MAPK activation (p38, ERK, JNK)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "enhanced glutamate release",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "confidence": 0.8,
      "evidence": "enhances glutamate release",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "ROS generation",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "confidence": 0.8,
      "evidence": "ROS generation",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "excitotoxicity",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "confidence": 0.85,
      "evidence": "promoting excitotoxicity",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "confidence": 0.9,
      "evidence": "depressed patients",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "production of pro-inflammatory cytokines",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "confidence": 0.85,
      "evidence": "production of pro-inflammatory cytokines",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Evidence",
      "name": "meta-analysis",
      "attributes": {
        "evidence_level": 1
      },
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "confidence": 0.9,
      "evidence": "meta-analyses show elevations",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "inflamed depression",
      "attributes": {
        "condition_type": "subgroup"
      },
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "confidence": 0.85,
      "evidence": "inflamed depression subgroup",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Condition",
      "name": "BD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "confidence": 0.9,
      "evidence": "In BD",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Condition",
      "name": "psychosis",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "confidence": 0.85,
      "evidence": "acute phases of depression, mania, and psychosis",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Effect",
      "name": "severity and treatment resistance",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "confidence": 0.8,
      "evidence": "linked to severity and treatment resistance",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "NOD1/2 receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "confidence": 0.9,
      "evidence": "NOD1/2 receptors detect bacterial peptidoglycans",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "NF-\u03baB",
      "attributes": {
        "target_type": "transcription factor"
      },
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "confidence": 0.95,
      "evidence": "NF-\u03baB activation",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "NLRP3 inflammasome",
      "attributes": {
        "target_type": "multiprotein complex"
      },
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "confidence": 0.95,
      "evidence": "NLRP3 inflammasome, a multiprotein complex",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "transcriptional upregulation of inflammasome components",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "confidence": 0.85,
      "evidence": "transcriptional upregulation of inflammasome components",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "cleavage of pro-IL-1\u03b2 and pro-IL-18 into active forms",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "confidence": 0.85,
      "evidence": "cleavage of pro-IL-1\u03b2 and pro-IL-18 into their active forms",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "pyroptotic cell death",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "confidence": 0.9,
      "evidence": "driving pyroptotic cell death",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "amplifying inflammatory cascades",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "confidence": 0.85,
      "evidence": "amplifying inflammatory cascades",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Preclinical studies",
      "attributes": {
        "design": "preclinical"
      },
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "confidence": 0.8,
      "evidence": "Preclinical studies show",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Evidence",
      "name": "preclinical evidence",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "confidence": 0.8,
      "evidence": "Preclinical studies show",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "chronic stress",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "confidence": 0.9,
      "evidence": "chronic stress enhances NLRP3 activation",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "increased IL-1\u03b2 release",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "confidence": 0.85,
      "evidence": "increased IL-1\u03b2 release",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "inhibition of neurogenesis",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "confidence": 0.85,
      "evidence": "inhibition of neurogenesis",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "disruption of synaptic plasticity",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "confidence": 0.85,
      "evidence": "disruption of synaptic plasticity",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "depressive-like behavior",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "confidence": 0.9,
      "evidence": "emergence of depressive-like behavior",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "confidence": 0.8,
      "evidence": "depressive-like behavior",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "NLRP3 inflammasome",
      "attributes": {
        "target_type": "inflammasome"
      },
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.95,
      "evidence": "NLRP3 inflammasome",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "MCC950",
      "attributes": {},
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.9,
      "evidence": "MCC950",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "restoring neuroplasticity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.85,
      "evidence": "restoring neuroplasticity",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "behavioral resilience",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.85,
      "evidence": "behavioral resilience",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "animal models",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.8,
      "evidence": "animal models",
      "verified": true
    },
    {
      "id": "E6",
      "type": "CompoundClass",
      "name": "conventional antidepressants",
      "attributes": {},
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.9,
      "evidence": "conventional antidepressants",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "IL-1\u03b2 release",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.85,
      "evidence": "IL-1\u03b2 release",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "reduce NLRP3 activation",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.85,
      "evidence": "reduce NLRP3 activation",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Evidence",
      "name": "experimental models",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.8,
      "evidence": "experimental models",
      "verified": true
    },
    {
      "id": "E10",
      "type": "CompoundClass",
      "name": "conventional monoaminergic antidepressants",
      "attributes": {},
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.9,
      "evidence": "conventional monoaminergic antidepressants",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "synaptic serotonin",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.85,
      "evidence": "synaptic serotonin",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "norepinephrine",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.85,
      "evidence": "norepinephrine",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "promote downstream plasticity adaptations",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.8,
      "evidence": "promote downstream plasticity adaptations",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.9,
      "evidence": "antidepressant outcomes",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Target",
      "name": "CRP",
      "attributes": {
        "target_type": "biomarker"
      },
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.9,
      "evidence": "CRP",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Compound",
      "name": "escitalopram",
      "attributes": {},
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.9,
      "evidence": "escitalopram",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Compound",
      "name": "nortriptyline",
      "attributes": {},
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.9,
      "evidence": "nortriptyline",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Compound",
      "name": "bupropion",
      "attributes": {},
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.9,
      "evidence": "bupropion",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Target",
      "name": "NOD receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.85,
      "evidence": "NOD receptors",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Target",
      "name": "TLR4",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.85,
      "evidence": "TLR4",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Condition",
      "name": "mood disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "confidence": 0.9,
      "evidence": "mood disorders",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "inflammatory depression",
      "attributes": {
        "condition_type": "phenotype"
      },
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "confidence": 0.9,
      "evidence": "inflammatory depression phenotype",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "mitochondrial dysfunction",
      "attributes": {
        "condition_type": "biological process"
      },
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "confidence": 0.85,
      "evidence": "mitochondrial dysfunction",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "oxidative stress",
      "attributes": {
        "condition_type": "biological process"
      },
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "confidence": 0.85,
      "evidence": "oxidative stress",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "glial activation",
      "attributes": {
        "condition_type": "biological process"
      },
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "confidence": 0.85,
      "evidence": "glial activation",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "impaired neuroimmune homeostasis",
      "attributes": {
        "condition_type": "biological process"
      },
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "confidence": 0.85,
      "evidence": "impaired neuroimmune homeostasis",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "neurotrophic alterations",
      "attributes": {
        "condition_type": "biological process"
      },
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "confidence": 0.85,
      "evidence": "neurotrophic alterations",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "synaptic alterations",
      "attributes": {
        "condition_type": "biological process"
      },
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "confidence": 0.85,
      "evidence": "synaptic alterations",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "dysregulation of the kynurenine pathway",
      "attributes": {
        "condition_type": "biological process"
      },
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "confidence": 0.85,
      "evidence": "dysregulation of the kynurenine pathway",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "MDD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "confidence": 0.9,
      "evidence": "MDD",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "BD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "confidence": 0.9,
      "evidence": "BD",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "fatigue",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "confidence": 0.9,
      "evidence": "fatigue",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "cognitive impairment",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "confidence": 0.9,
      "evidence": "cognitive impairment",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Condition",
      "name": "anhedonia",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "confidence": 0.9,
      "evidence": "anhedonia",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "reduced responsiveness to conventional treatments",
      "attributes": {
        "condition_type": "clinical dimension"
      },
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "confidence": 0.85,
      "evidence": "reduced responsiveness to conventional treatments",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "mood disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "0dc9ba4547cc461a1210b8e6a764d8c3"
      ],
      "confidence": 0.95,
      "evidence": "mood disorders",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "meta-analysis",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "0dc9ba4547cc461a1210b8e6a764d8c3"
      ],
      "confidence": 0.9,
      "evidence": "meta-analysis by Liu et al. (2015)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Liu et al. (2015)",
      "attributes": {
        "design": "meta-analysis",
        "year": 2015
      },
      "source_chunk_ids": [
        "0dc9ba4547cc461a1210b8e6a764d8c3"
      ],
      "confidence": 0.85,
      "evidence": "meta-analysis by Liu et al. (2015)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "redox balance",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "0dc9ba4547cc461a1210b8e6a764d8c3"
      ],
      "confidence": 0.8,
      "evidence": "targeting redox balance",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Berk et al. (2008)",
      "attributes": {
        "design": "clinical trial",
        "year": 2008
      },
      "source_chunk_ids": [
        "0dc9ba4547cc461a1210b8e6a764d8c3"
      ],
      "confidence": 0.85,
      "evidence": "Berk et al. (2008)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "NAC",
      "attributes": {},
      "source_chunk_ids": [
        "0dc9ba4547cc461a1210b8e6a764d8c3"
      ],
      "confidence": 0.9,
      "evidence": "NAC supplementation",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "glutathione",
      "attributes": {
        "target_type": "molecule"
      },
      "source_chunk_ids": [
        "0dc9ba4547cc461a1210b8e6a764d8c3"
      ],
      "confidence": 0.8,
      "evidence": "replenishes glutathione",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "improves symptoms",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "0dc9ba4547cc461a1210b8e6a764d8c3"
      ],
      "confidence": 0.75,
      "evidence": "improves symptoms",
      "verified": true
    },
    {
      "id": "E1",
      "type": "CompoundClass",
      "name": "omega-3 fatty acids",
      "attributes": {},
      "source_chunk_ids": [
        "cbb9f7601073a2259c0b3640b104e011"
      ],
      "confidence": 0.9,
      "evidence": "omega-3 fatty acids",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "antioxidant effect",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "cbb9f7601073a2259c0b3640b104e011"
      ],
      "confidence": 0.85,
      "evidence": "exert antioxidant effects",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "anti-inflammatory effect",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "cbb9f7601073a2259c0b3640b104e011"
      ],
      "confidence": 0.85,
      "evidence": "exert anti-inflammatory effects",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "creatine",
      "attributes": {},
      "source_chunk_ids": [
        "cbb9f7601073a2259c0b3640b104e011"
      ],
      "confidence": 0.9,
      "evidence": "creatine",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "enhances bioenergetics",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "cbb9f7601073a2259c0b3640b104e011"
      ],
      "confidence": 0.8,
      "evidence": "enhances bioenergetics",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "mitochondrial dysfunction",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "cbb9f7601073a2259c0b3640b104e011"
      ],
      "confidence": 0.85,
      "evidence": "mitochondrial dysfunction",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "fatigue",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "cbb9f7601073a2259c0b3640b104e011"
      ],
      "confidence": 0.9,
      "evidence": "fatigue",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "psychomotor slowing",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "cbb9f7601073a2259c0b3640b104e011"
      ],
      "confidence": 0.85,
      "evidence": "psychomotor slowing",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "poor treatment response",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "cbb9f7601073a2259c0b3640b104e011"
      ],
      "confidence": 0.8,
      "evidence": "poor treatment response",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "IL-6",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "confidence": 0.95,
      "evidence": "IL-6",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "TNF-\u03b1",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "confidence": 0.95,
      "evidence": "TNF-\u03b1",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "IL-1\u03b2",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "confidence": 0.95,
      "evidence": "IL-1\u03b2",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "IL-6R",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "confidence": 0.9,
      "evidence": "IL-6R",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "TNF-\u03b1R",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "confidence": 0.9,
      "evidence": "TNF-\u03b1R",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "IL-1\u03b2R",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "confidence": 0.9,
      "evidence": "IL-1\u03b2R",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "JAK/STAT3 pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "confidence": 0.85,
      "evidence": "JAK/STAT3 pathway",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "NF-\u03baB pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "confidence": 0.85,
      "evidence": "NF-\u03baB pathway",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "MAPK pathways",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "confidence": 0.85,
      "evidence": "MAPK pathways",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "Neuroinflammation \u2191",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "confidence": 0.9,
      "evidence": "Neuroinflammation \u2191",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "Neuroplasticity \u2193",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "confidence": 0.9,
      "evidence": "Neuroplasticity \u2193",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "Glutamatergic dysregulation \u2191",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "confidence": 0.9,
      "evidence": "Glutamatergic dysregulation \u2191",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "Oxidative stress \u2191",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "confidence": 0.9,
      "evidence": "Oxidative stress \u2191",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "Treatment resistance \u2191",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "confidence": 0.85,
      "evidence": "Treatment resistance \u2191",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "IL-6R",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "5733fc14c1b0b62049161682875cde6c"
      ],
      "confidence": 0.9,
      "evidence": "IL-6R",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "TNFR",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "5733fc14c1b0b62049161682875cde6c"
      ],
      "confidence": 0.9,
      "evidence": "TNFR",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "IL-1\u03b2R",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "5733fc14c1b0b62049161682875cde6c"
      ],
      "confidence": 0.9,
      "evidence": "IL-1\u03b2R",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "JAK/STAT3",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "5733fc14c1b0b62049161682875cde6c"
      ],
      "confidence": 0.85,
      "evidence": "JAK/STAT3",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "NF-\u03baB",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "5733fc14c1b0b62049161682875cde6c"
      ],
      "confidence": 0.85,
      "evidence": "NF-\u03baB",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "MAPK pathways",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "5733fc14c1b0b62049161682875cde6c"
      ],
      "confidence": 0.85,
      "evidence": "MAPK pathways",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "astrocyte reactivity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "5733fc14c1b0b62049161682875cde6c"
      ],
      "confidence": 0.8,
      "evidence": "promoting astrocyte reactivity",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "pro-inflammatory gene programs",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "5733fc14c1b0b62049161682875cde6c"
      ],
      "confidence": 0.8,
      "evidence": "pro-inflammatory gene programs",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "amplify neuroinflammation",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "5733fc14c1b0b62049161682875cde6c"
      ],
      "confidence": 0.85,
      "evidence": "amplify neuroinflammation",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "impair neuroplasticity",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "5733fc14c1b0b62049161682875cde6c"
      ],
      "confidence": 0.85,
      "evidence": "impair neuroplasticity",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "disrupt glutamatergic homeostasis",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "5733fc14c1b0b62049161682875cde6c"
      ],
      "confidence": 0.85,
      "evidence": "disrupt glutamatergic homeostasis",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "increase oxidative/NO stress",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "5733fc14c1b0b62049161682875cde6c"
      ],
      "confidence": 0.8,
      "evidence": "increase oxidative/NO stress",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "contribute to treatment resistance",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "5733fc14c1b0b62049161682875cde6c"
      ],
      "confidence": 0.8,
      "evidence": "contribute to treatment resistance",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "microglia",
      "attributes": {
        "target_type": "immune cell"
      },
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "confidence": 0.9,
      "evidence": "Microglia and astrocytes form the primary immune regulators",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "astrocytes",
      "attributes": {
        "target_type": "immune cell"
      },
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "confidence": 0.9,
      "evidence": "Microglia and astrocytes form the primary immune regulators",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "M1-like pro-inflammatory phenotype",
      "attributes": {
        "target_type": "phenotype"
      },
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "confidence": 0.85,
      "evidence": "microglia polarize toward an M1-like pro-inflammatory phenotype",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "M2-like phenotype",
      "attributes": {
        "target_type": "phenotype"
      },
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "confidence": 0.85,
      "evidence": "reparative M2-like phenotype",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "glutamate transporters (EAAT1/2)",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "confidence": 0.8,
      "evidence": "reduced expression of glutamate transporters (EAAT1/2)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "excitotoxicity",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "confidence": 0.8,
      "evidence": "contributing to excitotoxicity",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "synaptic pruning",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "confidence": 0.8,
      "evidence": "excitotoxicity and synaptic pruning",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "neurogenesis",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "confidence": 0.75,
      "evidence": "neurogenesis and tissue repair",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "tissue repair",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "confidence": 0.75,
      "evidence": "neurogenesis and tissue repair",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "blunted M2-like phenotype",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "confidence": 0.7,
      "evidence": "M2-like phenotype is blunted in mood disorders",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "impaired glutamate clearance",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "confidence": 0.7,
      "evidence": "impairs clearance of excitatory neurotransmitters",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "mood disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "confidence": 0.85,
      "evidence": "blunted in mood disorders",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Condition",
      "name": "depressive phenotypes",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "confidence": 0.8,
      "evidence": "contributes to depressive phenotypes",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Study",
      "name": "Yirmiya et al. (2015)",
      "attributes": {
        "year": 2015
      },
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "confidence": 0.9,
      "evidence": "Yirmiya et al. (2015) reviewed",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Evidence",
      "name": "review",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "confidence": 0.8,
      "evidence": "Yirmiya et al. (2015) reviewed",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "confidence": 0.9,
      "evidence": "depressed patients",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "GFAP+ astrocytic density",
      "attributes": {
        "target_type": "cellular marker"
      },
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "confidence": 0.85,
      "evidence": "reduced GFAP+ astrocytic density",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "reduced trophic support",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "confidence": 0.8,
      "evidence": "reduce trophic support",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "impaired synaptic homeostasis",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "confidence": 0.8,
      "evidence": "impair synaptic homeostasis",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "amplified excitotoxic cascades",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "confidence": 0.8,
      "evidence": "amplify excitotoxic cascades",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Evidence",
      "name": "postmortem studies",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "confidence": 0.85,
      "evidence": "postmortem studies show",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "in vivo evidence",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "confidence": 0.8,
      "evidence": "In vivo evidence from TSPO-PET imaging",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Setiawan et al. (2015)",
      "attributes": {
        "year": 2015
      },
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "confidence": 0.9,
      "evidence": "Setiawan et al. (2015)",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "TSPO binding",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "confidence": 0.9,
      "evidence": "TSPO binding",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Eggerstorfer et al. (2022)",
      "attributes": {
        "year": 2022,
        "design": "meta-analysis"
      },
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "confidence": 0.9,
      "evidence": "meta-analysis by Eggerstorfer et al. (2022)",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Attwells et al. (2021)",
      "attributes": {
        "year": 2021
      },
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "confidence": 0.9,
      "evidence": "Attwells et al. (2021)",
      "verified": true
    },
    {
      "id": "E12",
      "type": "RawMaterial",
      "name": "minocycline",
      "attributes": {},
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "confidence": 0.85,
      "evidence": "minocycline",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Study",
      "name": "Raison et al. (2013)",
      "attributes": {
        "year": 2013
      },
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "confidence": 0.9,
      "evidence": "Raison et al. (2013)",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "CRP",
      "attributes": {
        "target_type": "biomarker"
      },
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "confidence": 0.85,
      "evidence": "CRP > 5 mg/L",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "antidepressant effects",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "confidence": 0.8,
      "evidence": "antidepressant effects",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Condition",
      "name": "inflammatory depression",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "confidence": 0.85,
      "evidence": "inflammatory depression",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "kynurenine pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "confidence": 0.9,
      "evidence": "kynurenine pathway (KP)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "IDO",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "confidence": 0.85,
      "evidence": "IDO",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "TDO",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "confidence": 0.85,
      "evidence": "TDO",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "tryptophan",
      "attributes": {},
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "confidence": 0.9,
      "evidence": "tryptophan",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "serotonin",
      "attributes": {},
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "confidence": 0.9,
      "evidence": "serotonin",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "kynurenine",
      "attributes": {},
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "confidence": 0.9,
      "evidence": "kynurenine",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "quinolinic acid",
      "attributes": {},
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "confidence": 0.9,
      "evidence": "quinolinic acid (QA)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "NMDA receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "confidence": 0.85,
      "evidence": "NMDA",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "kynurenic acid",
      "attributes": {},
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "confidence": 0.9,
      "evidence": "kynurenic acid (KYNA)",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "\u03b17 nicotinic receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "confidence": 0.85,
      "evidence": "\u03b17 nicotinic receptor",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "neurotoxicity",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "confidence": 0.8,
      "evidence": "neurotoxic",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "neuroprotection",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "confidence": 0.8,
      "evidence": "neuroprotective effects",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Evidence",
      "name": "meta-analysis",
      "attributes": {
        "evidence_level": 1
      },
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "confidence": 0.9,
      "evidence": "Meta-analyses consistently support",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Study",
      "name": "Marx et al. (2021)",
      "attributes": {
        "year": 2021
      },
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "confidence": 0.95,
      "evidence": "Marx et al. (2021) found",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Inam et al. (2023)",
      "attributes": {
        "year": 2023
      },
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "confidence": 0.95,
      "evidence": "Inam et al. (2023) confirmed",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "mood disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "confidence": 0.9,
      "evidence": "across mood disorders",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "MDD",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "confidence": 0.85,
      "evidence": "MDD patients",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "KYN/TRP ratio",
      "attributes": {},
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "confidence": 0.8,
      "evidence": "elevated KYN/TRP ratios",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "QA",
      "attributes": {},
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "confidence": 0.85,
      "evidence": "increased QA",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "KYNA",
      "attributes": {},
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "confidence": 0.85,
      "evidence": "reduced KYNA",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "3-hydroxykynurenine",
      "attributes": {},
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "confidence": 0.9,
      "evidence": "3-hydroxykynurenine (3-HK)",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "anthranilic acid",
      "attributes": {},
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "confidence": 0.9,
      "evidence": "anthranilic acid",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "oxidative stress",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "confidence": 0.85,
      "evidence": "contribute to oxidative stress",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "neuronal toxicity",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "confidence": 0.85,
      "evidence": "neuronal toxicity",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "suicidality",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "61542ad10d90622c39bc5acfb9ba8397"
      ],
      "confidence": 0.9,
      "evidence": "associated with suicidality",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Study",
      "name": "Sublette et al. (2011)",
      "attributes": {
        "year": 2011,
        "design": "observational"
      },
      "source_chunk_ids": [
        "61542ad10d90622c39bc5acfb9ba8397"
      ],
      "confidence": 0.85,
      "evidence": "Sublette et al. (2011) showed increased plasma kynurenine",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "61542ad10d90622c39bc5acfb9ba8397"
      ],
      "confidence": 0.8,
      "evidence": "showed increased plasma kynurenine",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "kynurenine pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "61542ad10d90622c39bc5acfb9ba8397"
      ],
      "confidence": 0.9,
      "evidence": "KP alterations are associated",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Agudelo et al. (2014)",
      "attributes": {
        "year": 2014,
        "design": "experimental"
      },
      "source_chunk_ids": [
        "61542ad10d90622c39bc5acfb9ba8397"
      ],
      "confidence": 0.85,
      "evidence": "Agudelo et al. (2014) demonstrated",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Evidence",
      "name": "experimental study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "61542ad10d90622c39bc5acfb9ba8397"
      ],
      "confidence": 0.8,
      "evidence": "demonstrated that obesity enhances IDO activity",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "obesity",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "61542ad10d90622c39bc5acfb9ba8397"
      ],
      "confidence": 0.9,
      "evidence": "obesity and insulin resistance",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "insulin resistance",
      "attributes": {
        "condition_type": "condition"
      },
      "source_chunk_ids": [
        "61542ad10d90622c39bc5acfb9ba8397"
      ],
      "confidence": 0.9,
      "evidence": "obesity and insulin resistance",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "IDO",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "61542ad10d90622c39bc5acfb9ba8397"
      ],
      "confidence": 0.85,
      "evidence": "enhance IDO activity",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "KP dysregulation",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "61542ad10d90622c39bc5acfb9ba8397"
      ],
      "confidence": 0.8,
      "evidence": "KP dysregulation provides mechanistic insight",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "mood disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "3cc7626e1cb2ebc24b6d93900726b33f"
      ],
      "confidence": 0.9,
      "evidence": "Neuroinflammation in mood disorders",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "prefrontal cortex",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "3cc7626e1cb2ebc24b6d93900726b33f"
      ],
      "confidence": 0.95,
      "evidence": "prefrontal cortex (PFC)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "hippocampus",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "3cc7626e1cb2ebc24b6d93900726b33f"
      ],
      "confidence": 0.9,
      "evidence": "hippocampus",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "amygdala",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "3cc7626e1cb2ebc24b6d93900726b33f"
      ],
      "confidence": 0.9,
      "evidence": "amygdala",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "striatum",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "3cc7626e1cb2ebc24b6d93900726b33f"
      ],
      "confidence": 0.9,
      "evidence": "striatum",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "insula",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "3cc7626e1cb2ebc24b6d93900726b33f"
      ],
      "confidence": 0.9,
      "evidence": "insula",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "major depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "3cc7626e1cb2ebc24b6d93900726b33f"
      ],
      "confidence": 0.95,
      "evidence": "major depression",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "bipolar disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "3cc7626e1cb2ebc24b6d93900726b33f"
      ],
      "confidence": 0.95,
      "evidence": "bipolar disorder",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "anterior cingulate",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "3cc7626e1cb2ebc24b6d93900726b33f"
      ],
      "confidence": 0.9,
      "evidence": "anterior cingulate",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "postmortem studies",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "3cc7626e1cb2ebc24b6d93900726b33f"
      ],
      "confidence": 0.85,
      "evidence": "postmortem studies",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Evidence",
      "name": "neuroimaging",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "3cc7626e1cb2ebc24b6d93900726b33f"
      ],
      "confidence": 0.85,
      "evidence": "neuroimaging",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Evidence",
      "name": "animal models",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "3cc7626e1cb2ebc24b6d93900726b33f"
      ],
      "confidence": 0.8,
      "evidence": "animal models",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Evidence",
      "name": "PET imaging studies",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "3cc7626e1cb2ebc24b6d93900726b33f"
      ],
      "confidence": 0.85,
      "evidence": "PET imaging studies",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "inflamed depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "confidence": 0.9,
      "evidence": "inflamed depression",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "prefrontal\u2013amygdala connectivity",
      "attributes": {
        "target_type": "neural connectivity"
      },
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "confidence": 0.85,
      "evidence": "impaired prefrontal\u2013amygdala connectivity",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "hippocampus",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "confidence": 0.9,
      "evidence": "hippocampus shows strong evidence",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "microglial activation",
      "attributes": {
        "target_type": "cellular process"
      },
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "confidence": 0.85,
      "evidence": "Microglial activation",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "astrocyte dysfunction",
      "attributes": {
        "target_type": "cellular process"
      },
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "confidence": 0.85,
      "evidence": "astrocyte dysfunction",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "neurogenesis in the dentate gyrus",
      "attributes": {
        "target_type": "cellular process"
      },
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "confidence": 0.85,
      "evidence": "downregulation of neurogenesis in the dentate gyrus",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "major depressive disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "confidence": 0.95,
      "evidence": "major depressive disorder",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "hippocampal neuronal survival",
      "attributes": {
        "target_type": "cellular process"
      },
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "confidence": 0.85,
      "evidence": "hippocampal neuronal survival is decreased",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "Urolithin B",
      "attributes": {},
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "confidence": 0.9,
      "evidence": "Urolithin B",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "restore neuronal function",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "confidence": 0.8,
      "evidence": "restore neuronal function",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "reduce depressive behavior",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "confidence": 0.8,
      "evidence": "reduce depressive behavior",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "amygdala",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "confidence": 0.9,
      "evidence": "amygdala involvement in mood disorders",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "microglial activation in amygdala",
      "attributes": {
        "target_type": "cellular process"
      },
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "confidence": 0.85,
      "evidence": "increased microglial activation",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "inflammatory cytokine expression in amygdala",
      "attributes": {
        "target_type": "cellular process"
      },
      "source_chunk_ids": [
        "b03a801bb0c1e8f940e176ef8daf1",
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "confidence": 0.85,
      "evidence": "inflammatory cytokine expression",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Target",
      "name": "reward circuitry",
      "attributes": {
        "target_type": "neural circuit"
      },
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "confidence": 0.85,
      "evidence": "Reward circuitry",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Target",
      "name": "nucleus accumbens/ventral striatum",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "confidence": 0.85,
      "evidence": "nucleus accumbens/ventral striatum",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Effect",
      "name": "blunted reward response",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "confidence": 0.8,
      "evidence": "blunted reward response",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Effect",
      "name": "reduced connectivity in reward circuitry",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "confidence": 0.8,
      "evidence": "reduced connectivity",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "insula",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "418ec92073545e5e7e49070f89353e04"
      ],
      "confidence": 0.9,
      "evidence": "The insula also shows elevated TSPO binding",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "418ec92073545e5e7e49070f89353e04"
      ],
      "confidence": 0.95,
      "evidence": "PET studies of depression",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "altered insular activity",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "418ec92073545e5e7e49070f89353e04"
      ],
      "confidence": 0.85,
      "evidence": "altered insular activity during interoceptive and affective tasks",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "high inflammatory states",
      "attributes": {
        "condition_type": "state"
      },
      "source_chunk_ids": [
        "418ec92073545e5e7e49070f89353e04"
      ],
      "confidence": 0.8,
      "evidence": "patients with high inflammatory states",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "abnormal salience processing",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "418ec92073545e5e7e49070f89353e04"
      ],
      "confidence": 0.75,
      "evidence": "consistent with abnormal salience processing",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.95,
      "evidence": "inflammation\u2013depression link",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "mood dysregulation",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.85,
      "evidence": "increase susceptibility to mood dysregulation",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "perimenopause",
      "attributes": {
        "condition_type": "condition"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.9,
      "evidence": "Perimenopause, in particular, is linked to higher rates of depression",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "late-life depression",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.85,
      "evidence": "enhances vulnerability to late-life depression",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "neuroimmune signaling",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.8,
      "evidence": "key modulators of neuroimmune signaling",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "microglial activation",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.75,
      "evidence": "reduce microglial activation",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "inflammatory signaling",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.75,
      "evidence": "dampen inflammatory signaling",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "neuroimmune balance",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.7,
      "evidence": "destabilize neuroimmune balance",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "pro-inflammatory cytokines",
      "attributes": {
        "target_type": "molecule"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.8,
      "evidence": "reduced production of pro-inflammatory cytokines",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "IL-6",
      "attributes": {
        "target_type": "molecule"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.85,
      "evidence": "increases in IL-6",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "TNF-\u03b1",
      "attributes": {
        "target_type": "molecule"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.85,
      "evidence": "increases in TNF-\u03b1",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "CRP",
      "attributes": {
        "target_type": "molecule"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.85,
      "evidence": "increases in CRP",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "stronger innate and adaptive immune responses",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.8,
      "evidence": "Women generally mount stronger innate and adaptive immune responses",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "greater vulnerability to inflammation-related depressive phenotypes",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.75,
      "evidence": "greater vulnerability to inflammation-related depressive phenotypes",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "reduce microglial activation and dampen inflammatory signaling",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.7,
      "evidence": "estrogens and progesterone can reduce microglial activation and dampen inflammatory signaling",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Effect",
      "name": "destabilize neuroimmune balance and increase susceptibility to mood dysregulation",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.7,
      "evidence": "destabilize neuroimmune balance and increase susceptibility to mood dysregulation",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Effect",
      "name": "higher rates of depression",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.8,
      "evidence": "Perimenopause is linked to higher rates of depression",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Effect",
      "name": "trigger symptoms in vulnerable women",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.75,
      "evidence": "estradiol withdrawal can trigger symptoms in vulnerable women",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Effect",
      "name": "anti-inflammatory effects on myeloid cells",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.7,
      "evidence": "Testosterone is generally associated with anti-inflammatory effects on myeloid cells",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Effect",
      "name": "reduced production of pro-inflammatory cytokines",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.75,
      "evidence": "reduced production of pro-inflammatory cytokines",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Effect",
      "name": "enhances vulnerability to late-life depression",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.8,
      "evidence": "enhances vulnerability to late-life depression",
      "verified": true
    },
    {
      "id": "E22",
      "type": "Effect",
      "name": "higher depressive burden and stronger reactivity to inflammatory stressors",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "confidence": 0.75,
      "evidence": "higher depressive burden and stronger reactivity to inflammatory stressors",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Evidence",
      "name": "translational research",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "confidence": 0.8,
      "evidence": "Translational research strongly suggests",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "immune-inflammatory mechanisms",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "confidence": 0.85,
      "evidence": "immune-inflammatory mechanisms contribute to mood disorders",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "mood disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "confidence": 0.9,
      "evidence": "contribute to mood disorders",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "study on celecoxib in MDD and BD",
      "attributes": {
        "design": "clinical trial"
      },
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "confidence": 0.75,
      "evidence": "Adjunctive celecoxib has demonstrated antidepressant efficacy",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "celecoxib",
      "attributes": {},
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "confidence": 0.95,
      "evidence": "Adjunctive celecoxib",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "MDD",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "confidence": 0.9,
      "evidence": "antidepressant efficacy in MDD",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "BD",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "confidence": 0.9,
      "evidence": "antimanic effects in BD",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "study on infliximab in inflammation",
      "attributes": {
        "design": "clinical trial"
      },
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "confidence": 0.75,
      "evidence": "infliximab improved symptoms only in patients",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "infliximab",
      "attributes": {},
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "confidence": 0.95,
      "evidence": "infliximab improved symptoms",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "elevated baseline inflammation",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "confidence": 0.8,
      "evidence": "patients with elevated baseline inflammation",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "anti-inflammatory strategies",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "confidence": 0.8,
      "evidence": "anti-inflammatory strategies are not universally effective",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "immune activation",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "confidence": 0.8,
      "evidence": "subgroups defined by immune activation",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "oxidative stress",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "confidence": 0.85,
      "evidence": "counteract the oxidative stress",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "bioenergetic dysfunction",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "confidence": 0.85,
      "evidence": "bioenergetic dysfunction",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Compound",
      "name": "N-acetylcysteine",
      "attributes": {},
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "confidence": 0.95,
      "evidence": "N-acetylcysteine aim to counteract",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "kynurenine pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "a0c7331a1f1d55df900d5d2469cddb07"
      ],
      "confidence": 0.9,
      "evidence": "kynurenine pathway",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "suicidality",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "a0c7331a1f1d55df900d5d2469cddb07"
      ],
      "confidence": 0.85,
      "evidence": "link with suicidality",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "treatment resistance",
      "attributes": {
        "condition_type": "condition"
      },
      "source_chunk_ids": [
        "a0c7331a1f1d55df900d5d2469cddb07"
      ],
      "confidence": 0.85,
      "evidence": "treatment resistance",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "gut microbiome",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "a0c7331a1f1d55df900d5d2469cddb07"
      ],
      "confidence": 0.9,
      "evidence": "gut microbiome",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "early interventions",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "a0c7331a1f1d55df900d5d2469cddb07"
      ],
      "confidence": 0.7,
      "evidence": "early probiotic and prebiotic interventions",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "modest benefits",
      "attributes": {
        "level": "systemic",
        "valence": "positive",
        "verification_needed": true
      },
      "source_chunk_ids": [
        "a0c7331a1f1d55df900d5d2469cddb07"
      ],
      "confidence": 0.65,
      "evidence": "modest but inconsistent benefits",
      "verified": false
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "infliximab trial in treatment-resistant depression",
      "attributes": {
        "design": "clinical trial",
        "notes": "mentioned in reference [80]"
      },
      "source_chunk_ids": [
        "4e545ee27a329f8d3b73c5558da2d6db"
      ],
      "confidence": 0.8,
      "evidence": "infliximab produced benefits in patients",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical trial evidence",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "4e545ee27a329f8d3b73c5558da2d6db"
      ],
      "confidence": 0.75,
      "evidence": "clinical translation of immunomodulatory strategies",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "treatment-resistant depression",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "4e545ee27a329f8d3b73c5558da2d6db"
      ],
      "confidence": 0.9,
      "evidence": "treatment-resistant depression",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "CRP > 5 mg/L",
      "attributes": {
        "condition_type": "biomarker"
      },
      "source_chunk_ids": [
        "4e545ee27a329f8d3b73c5558da2d6db"
      ],
      "confidence": 0.7,
      "evidence": "CRP > 5 mg/L",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Evidence",
      "name": "meta-analyses",
      "attributes": {
        "evidence_level": 1
      },
      "source_chunk_ids": [
        "7b1cfbb0fde4d880e904afbaa3ece060"
      ],
      "confidence": 0.9,
      "evidence": "meta-analyses of COX-2 inhibitors",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "MDD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "7b1cfbb0fde4d880e904afbaa3ece060"
      ],
      "confidence": 0.85,
      "evidence": "beneficial effects in MDD",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "BD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "7b1cfbb0fde4d880e904afbaa3ece060"
      ],
      "confidence": 0.85,
      "evidence": "less consistent findings in BD",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "COX-2",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "7b1cfbb0fde4d880e904afbaa3ece060"
      ],
      "confidence": 0.8,
      "evidence": "COX-2 inhibitors",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "beneficial effects",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "7b1cfbb0fde4d880e904afbaa3ece060"
      ],
      "confidence": 0.75,
      "evidence": "beneficial effects in MDD",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "less consistent findings",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "7b1cfbb0fde4d880e904afbaa3ece060"
      ],
      "confidence": 0.7,
      "evidence": "less consistent findings in BD",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "TSPO-PET studies",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "7b1cfbb0fde4d880e904afbaa3ece060"
      ],
      "confidence": 0.85,
      "evidence": "TSPO-PET studies",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "robust increases in microglial activation",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "7b1cfbb0fde4d880e904afbaa3ece060"
      ],
      "confidence": 0.8,
      "evidence": "robust increases in microglial activation",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "modest or null results",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "7b1cfbb0fde4d880e904afbaa3ece060"
      ],
      "confidence": 0.75,
      "evidence": "modest or null results",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "CRP",
      "attributes": {
        "target_type": "biomarker"
      },
      "source_chunk_ids": [
        "5d22968f7a6c6c228135d16018264678"
      ],
      "confidence": 0.8,
      "evidence": "Inflammatory biomarkers (CRP, IL-6, TNF-\u03b1, IL-1\u03b2)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "IL-6",
      "attributes": {
        "target_type": "biomarker"
      },
      "source_chunk_ids": [
        "5d22968f7a6c6c228135d16018264678"
      ],
      "confidence": 0.8,
      "evidence": "Inflammatory biomarkers (CRP, IL-6, TNF-\u03b1, IL-1\u03b2)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "TNF-\u03b1",
      "attributes": {
        "target_type": "biomarker"
      },
      "source_chunk_ids": [
        "5d22968f7a6c6c228135d16018264678"
      ],
      "confidence": 0.8,
      "evidence": "Inflammatory biomarkers (CRP, IL-6, TNF-\u03b1, IL-1\u03b2)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "IL-1\u03b2",
      "attributes": {
        "target_type": "biomarker"
      },
      "source_chunk_ids": [
        "5d22968f7a6c6c228135d16018264678"
      ],
      "confidence": 0.8,
      "evidence": "Inflammatory biomarkers (CRP, IL-6, TNF-\u03b1, IL-1\u03b2)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "TSPO",
      "attributes": {
        "target_type": "imaging_target"
      },
      "source_chunk_ids": [
        "5d22968f7a6c6c228135d16018264678"
      ],
      "confidence": 0.7,
      "evidence": "Neuroimaging (TSPO-PET)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "gut dysbiosis",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "5d22968f7a6c6c228135d16018264678"
      ],
      "confidence": 0.7,
      "evidence": "Gut dysbiosis (pro-inflammatory bacteria)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "mood disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "5d22968f7a6c6c228135d16018264678"
      ],
      "confidence": 0.9,
      "evidence": "therapeutic targets and clinical translation in mood disorders",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "Multi-omics clustering",
      "attributes": {
        "level": "molecular",
        "valence": "neutral",
        "verification_needed": true
      },
      "source_chunk_ids": [
        "5d22968f7a6c6c228135d16018264678"
      ],
      "confidence": 0.6,
      "evidence": "central process of 'Multi-omics clustering'",
      "verified": false
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "Emerging therapeutic approaches",
      "attributes": {
        "level": "systemic",
        "valence": "positive",
        "verification_needed": true
      },
      "source_chunk_ids": [
        "5d22968f7a6c6c228135d16018264678"
      ],
      "confidence": 0.6,
      "evidence": "leads to 'Emerging therapeutic approaches'",
      "verified": false
    },
    {
      "id": "E10",
      "type": "Product",
      "name": "Infliximab",
      "attributes": {},
      "source_chunk_ids": [
        "5d22968f7a6c6c228135d16018264678"
      ],
      "confidence": 0.8,
      "evidence": "Anti-TNF\u03b1 (Infliximab)",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Product",
      "name": "Celecoxib",
      "attributes": {},
      "source_chunk_ids": [
        "5d22968f7a6c6c228135d16018264678"
      ],
      "confidence": 0.8,
      "evidence": "COX2-inhibitors (Celecoxib)",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Product",
      "name": "Probiotics",
      "attributes": {},
      "source_chunk_ids": [
        "5d22968f7a6c6c228135d16018264678"
      ],
      "confidence": 0.8,
      "evidence": "Probiotics",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "CRP",
      "attributes": {
        "target_type": "biomarker"
      },
      "source_chunk_ids": [
        "ed7f14b69369a171658cb05467fdb23d"
      ],
      "confidence": 0.9,
      "evidence": "Peripheral biomarkers (CRP, IL-6, TNF-\u03b1, and IL-1\u03b2)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "IL-6",
      "attributes": {
        "target_type": "biomarker"
      },
      "source_chunk_ids": [
        "ed7f14b69369a171658cb05467fdb23d"
      ],
      "confidence": 0.9,
      "evidence": "Peripheral biomarkers (CRP, IL-6, TNF-\u03b1, and IL-1\u03b2)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "TNF-\u03b1",
      "attributes": {
        "target_type": "biomarker"
      },
      "source_chunk_ids": [
        "ed7f14b69369a171658cb05467fdb23d"
      ],
      "confidence": 0.9,
      "evidence": "Peripheral biomarkers (CRP, IL-6, TNF-\u03b1, and IL-1\u03b2)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "IL-1\u03b2",
      "attributes": {
        "target_type": "biomarker"
      },
      "source_chunk_ids": [
        "ed7f14b69369a171658cb05467fdb23d"
      ],
      "confidence": 0.9,
      "evidence": "Peripheral biomarkers (CRP, IL-6, TNF-\u03b1, and IL-1\u03b2)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "TSPO-PET",
      "attributes": {
        "target_type": "neuroimaging marker"
      },
      "source_chunk_ids": [
        "ed7f14b69369a171658cb05467fdb23d"
      ],
      "confidence": 0.85,
      "evidence": "neuroimaging markers (TSPO-PET)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "mood disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "ed7f14b69369a171658cb05467fdb23d"
      ],
      "confidence": 0.95,
      "evidence": "neuroinflammation research in mood disorders",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "celecoxib",
      "attributes": {},
      "source_chunk_ids": [
        "ed7f14b69369a171658cb05467fdb23d"
      ],
      "confidence": 0.8,
      "evidence": "COX-2 inhibitors (e.g., celecoxib)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "infliximab",
      "attributes": {},
      "source_chunk_ids": [
        "ed7f14b69369a171658cb05467fdb23d"
      ],
      "confidence": 0.8,
      "evidence": "anti-TNF-\u03b1 treatments (e.g., infliximab)",
      "verified": true
    },
    {
      "id": "E9",
      "type": "TraditionalUse",
      "name": "probiotic interventions",
      "attributes": {},
      "source_chunk_ids": [
        "ed7f14b69369a171658cb05467fdb23d"
      ],
      "confidence": 0.75,
      "evidence": "probiotic interventions",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "mood disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "900a374da5bfda5636d242b8bf9d42cd"
      ],
      "confidence": 0.9,
      "evidence": "mood disorders",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "900a374da5bfda5636d242b8bf9d42cd"
      ],
      "confidence": 0.95,
      "evidence": "develop depression",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "depressive symptoms",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "900a374da5bfda5636d242b8bf9d42cd"
      ],
      "confidence": 0.9,
      "evidence": "depressive symptoms",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "anhedonia",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "900a374da5bfda5636d242b8bf9d42cd"
      ],
      "confidence": 0.85,
      "evidence": "anhedonia",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "dysphoria",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "900a374da5bfda5636d242b8bf9d42cd"
      ],
      "confidence": 0.85,
      "evidence": "dysphoria",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "inflammation",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "900a374da5bfda5636d242b8bf9d42cd"
      ],
      "confidence": 0.9,
      "evidence": "inflammation causes mood disorders",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "immune activation",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "900a374da5bfda5636d242b8bf9d42cd"
      ],
      "confidence": 0.85,
      "evidence": "immune activation can precipitate depressive symptoms",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "IL-6",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "900a374da5bfda5636d242b8bf9d42cd"
      ],
      "confidence": 0.8,
      "evidence": "increases in IL-6",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "TNF-\u03b1",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "900a374da5bfda5636d242b8bf9d42cd"
      ],
      "confidence": 0.8,
      "evidence": "increases in TNF-\u03b1",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "clinical evidence",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "900a374da5bfda5636d242b8bf9d42cd"
      ],
      "confidence": 0.75,
      "evidence": "Current evidence indicates",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "5d848fa6fd4b8ef3419d2d7874846d14"
      ],
      "confidence": 0.95,
      "evidence": "depression itself promotes inflammatory activity",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "HPA-axis",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "5d848fa6fd4b8ef3419d2d7874846d14"
      ],
      "confidence": 0.8,
      "evidence": "HPA-axis dysregulation",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "CRP",
      "attributes": {
        "target_type": "biomarker"
      },
      "source_chunk_ids": [
        "5d848fa6fd4b8ef3419d2d7874846d14"
      ],
      "confidence": 0.85,
      "evidence": "increases in CRP",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "IL-6",
      "attributes": {
        "target_type": "biomarker"
      },
      "source_chunk_ids": [
        "5d848fa6fd4b8ef3419d2d7874846d14"
      ],
      "confidence": 0.85,
      "evidence": "increases in CRP and IL-6",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "prospective cohort study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "5d848fa6fd4b8ef3419d2d7874846d14"
      ],
      "confidence": 0.8,
      "evidence": "Prospective cohorts demonstrate this reverse pathway",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Study [113]",
      "attributes": {
        "design": "prospective cohort",
        "year": null,
        "doi": null
      },
      "source_chunk_ids": [
        "5d848fa6fd4b8ef3419d2d7874846d14"
      ],
      "confidence": 0.7,
      "evidence": "[113]",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "major depressive disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "8b002f39b5015b8d77dcd80bf739e960"
      ],
      "confidence": 0.95,
      "evidence": "major depressive disorder (MDD)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "neuroinflammation evidence",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "8b002f39b5015b8d77dcd80bf739e960"
      ],
      "confidence": 0.8,
      "evidence": "Evidence on immune\u2013inflammatory dysregulation",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "immune\u2013inflammatory dysregulation",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "8b002f39b5015b8d77dcd80bf739e960"
      ],
      "confidence": 0.85,
      "evidence": "immune\u2013inflammatory dysregulation in major depressive disorder",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "neuroinflammation",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "8b002f39b5015b8d77dcd80bf739e960"
      ],
      "confidence": 0.9,
      "evidence": "role of neuroinflammation in major depressive disorder",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "peripheral biomarkers",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "8b002f39b5015b8d77dcd80bf739e960"
      ],
      "confidence": 0.7,
      "evidence": "peripheral biomarkers",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "kynurenine pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "8b002f39b5015b8d77dcd80bf739e960"
      ],
      "confidence": 0.7,
      "evidence": "kynurenine pathway",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "neuroimaging",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "8b002f39b5015b8d77dcd80bf739e960"
      ],
      "confidence": 0.7,
      "evidence": "neuroimaging",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "oxidative stress",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "8b002f39b5015b8d77dcd80bf739e960"
      ],
      "confidence": 0.7,
      "evidence": "oxidative stress",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "gut\u2013brain axis",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "8b002f39b5015b8d77dcd80bf739e960"
      ],
      "confidence": 0.7,
      "evidence": "gut\u2013brain axis",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "interventional studies",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "8b002f39b5015b8d77dcd80bf739e960"
      ],
      "confidence": 0.7,
      "evidence": "interventional studies",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "mood disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "b0933ef91a1a882105fc3b8f53404712"
      ],
      "confidence": 0.95,
      "evidence": "mood disorders",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "NF-\u03baB",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "b0933ef91a1a882105fc3b8f53404712"
      ],
      "confidence": 0.9,
      "evidence": "NF-\u03baB",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "JAK/STAT",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "b0933ef91a1a882105fc3b8f53404712"
      ],
      "confidence": 0.9,
      "evidence": "JAK/STAT",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "MAPK",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "b0933ef91a1a882105fc3b8f53404712"
      ],
      "confidence": 0.9,
      "evidence": "MAPK",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "NLRP3",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "b0933ef91a1a882105fc3b8f53404712"
      ],
      "confidence": 0.9,
      "evidence": "NLRP3 pathways",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "mitochondria",
      "attributes": {
        "target_type": "cellular component"
      },
      "source_chunk_ids": [
        "b0933ef91a1a882105fc3b8f53404712"
      ],
      "confidence": 0.85,
      "evidence": "mitochondria",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "glia",
      "attributes": {
        "target_type": "cellular component"
      },
      "source_chunk_ids": [
        "b0933ef91a1a882105fc3b8f53404712"
      ],
      "confidence": 0.85,
      "evidence": "glia",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "synaptic plasticity",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "b0933ef91a1a882105fc3b8f53404712"
      ],
      "confidence": 0.85,
      "evidence": "synaptic plasticity",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "kynurenine metabolism",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "b0933ef91a1a882105fc3b8f53404712"
      ],
      "confidence": 0.85,
      "evidence": "kynurenine metabolism",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "gut\u2013brain axis",
      "attributes": {
        "target_type": "interface"
      },
      "source_chunk_ids": [
        "b0933ef91a1a882105fc3b8f53404712"
      ],
      "confidence": 0.8,
      "evidence": "gut\u2013brain axis",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "blood\u2013brain barrier",
      "attributes": {
        "target_type": "interface"
      },
      "source_chunk_ids": [
        "b0933ef91a1a882105fc3b8f53404712"
      ],
      "confidence": 0.8,
      "evidence": "blood\u2013brain barrier",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "BDNF/TrkB signaling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "b0933ef91a1a882105fc3b8f53404712"
      ],
      "confidence": 0.85,
      "evidence": "BDNF/TrkB signaling",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "depressive disorders",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "confidence": 0.9,
      "evidence": "Depressive disorders: Treatment failures",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "bipolar depression",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "confidence": 0.9,
      "evidence": "Neuroinflammation in Bipolar Depression",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "major depression",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "confidence": 0.9,
      "evidence": "Inflammatory markers in depression",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "C-reactive protein",
      "attributes": {
        "target_type": "inflammatory marker"
      },
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "confidence": 0.85,
      "evidence": "C-reactive protein in major depressive disorder",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "tumor necrosis factor-\u03b1",
      "attributes": {
        "target_type": "inflammatory marker"
      },
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "confidence": 0.85,
      "evidence": "tumor necrosis factor-\u03b1 across the mood spectrum",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "interleukin-6",
      "attributes": {
        "target_type": "inflammatory marker"
      },
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "confidence": 0.85,
      "evidence": "interleukin-6 across the mood spectrum",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "interleukin-1\u03b2",
      "attributes": {
        "target_type": "inflammatory marker"
      },
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "confidence": 0.85,
      "evidence": "interleukin-1\u03b2 across the mood spectrum",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "blood-brain barrier",
      "attributes": {
        "target_type": "physiological barrier"
      },
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "confidence": 0.8,
      "evidence": "Blood-brain barrier regulation in psychiatric disorders",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "gut-brain barrier",
      "attributes": {
        "target_type": "physiological barrier"
      },
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "confidence": 0.8,
      "evidence": "The gut-brain barrier in major depression",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "NF-\u03baB",
      "attributes": {
        "target_type": "transcription factor"
      },
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "confidence": 0.85,
      "evidence": "Nuclear factor-\u03baB is a critical mediator",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "NLRP3 inflammasome",
      "attributes": {
        "target_type": "inflammatory complex"
      },
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "confidence": 0.85,
      "evidence": "The NLRP3 Inflammasome: An Overview",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "astrocytes",
      "attributes": {
        "target_type": "cell type"
      },
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "confidence": 0.8,
      "evidence": "Astrocyte pathology in major depressive disorder",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "microglia",
      "attributes": {
        "target_type": "cell type"
      },
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "confidence": 0.8,
      "evidence": "Depression as a microglial disease",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "oxidative stress",
      "attributes": {
        "target_type": "biological process"
      },
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "confidence": 0.8,
      "evidence": "A Meta-Analysis of Oxidative Stress Markers",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Target",
      "name": "brain-derived neurotrophic factor",
      "attributes": {
        "target_type": "neurotrophin"
      },
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "confidence": 0.85,
      "evidence": "Altered gene expression of brain-derived neurotrophic factor",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Effect",
      "name": "inflammation",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "confidence": 0.9,
      "evidence": "depression is an inflammatory disease",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Effect",
      "name": "neuroinflammation",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "confidence": 0.9,
      "evidence": "Neuroinflammation in Bipolar Depression",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Effect",
      "name": "impaired neurogenesis",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "confidence": 0.8,
      "evidence": "stress-impaired neurogenesis and depressive behavior",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Effect",
      "name": "depressive behavior",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "confidence": 0.8,
      "evidence": "stress-impaired neurogenesis and depressive behavior",
      "verified": true
    }
  ],
  "relationships": [
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E21",
      "target_entity_id": "E18",
      "attributes": {
        "outcome": "predicts"
      },
      "confidence": 0.8,
      "evidence": "elevated CRP and IL-6 predict poor antidepressant outcomes",
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E22",
      "target_entity_id": "E23",
      "attributes": {
        "outcome": "identifies"
      },
      "confidence": 0.75,
      "evidence": "identify immuno-metabolic biotypes",
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "characterized by greater severity",
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "characterized by cognitive impairment",
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "characterized by poor treatment response",
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E16",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "KP alterations, fostering excitotoxicity",
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E17",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "KP alterations, fostering synaptic deficits",
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "TREATS",
      "source_entity_id": "E19",
      "target_entity_id": "E1",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "infliximab show efficacy in specific subgroups",
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "TREATS",
      "source_entity_id": "E20",
      "target_entity_id": "E1",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "celecoxib show efficacy in specific subgroups",
      "source_chunk_ids": [
        "04b8be586369c3bce8a65a324f946720"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E23",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.85,
      "evidence": "low-grade systemic inflammation in both MDD",
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E23",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.85,
      "evidence": "low-grade systemic inflammation in both BD",
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E23",
      "target_entity_id": "E24",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "inflammatory mediators to access CNS and foster neuroinflammation",
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E24",
      "target_entity_id": "E25",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "contributing to excitotoxicity",
      "source_chunk_ids": [
        "2e985b1b49d7921540784ee9a2118750"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "HPA axis, leading to hypercortisolemia",
      "source_chunk_ids": [
        "42702aafa9f078fb65e9c3fd09001322"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "leading to hypercortisolemia, glucocorticoid receptor resistance",
      "source_chunk_ids": [
        "42702aafa9f078fb65e9c3fd09001322"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "leading to hypercortisolemia, glucocorticoid receptor resistance, and sustained low-grade inflammation",
      "source_chunk_ids": [
        "42702aafa9f078fb65e9c3fd09001322"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "These alterations potentiate the activation of NF-\u03baB",
      "source_chunk_ids": [
        "42702aafa9f078fb65e9c3fd09001322"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E2",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "These alterations potentiate the activation of NF-\u03baB and NLRP3-dependent cascades",
      "source_chunk_ids": [
        "42702aafa9f078fb65e9c3fd09001322"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "context": "sequential process"
      },
      "confidence": 0.7,
      "evidence": "linking peripheral immune activation to central neuroinflammation",
      "source_chunk_ids": [
        "e41a1d643678bd30f5fb493982c34a70"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {
        "context": "early events",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "gut dysbiosis and barrier permeability may represent early events",
      "source_chunk_ids": [
        "e41a1d643678bd30f5fb493982c34a70"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {
        "context": "followed by",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "followed by immune activation",
      "source_chunk_ids": [
        "e41a1d643678bd30f5fb493982c34a70"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {
        "context": "ultimately by",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "ultimately by neuroinflammatory changes",
      "source_chunk_ids": [
        "e41a1d643678bd30f5fb493982c34a70"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E3",
      "attributes": {
        "context": "contribute to",
        "assertion": "suggests",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "neuroinflammatory changes that may contribute to the emergence of mood disorders",
      "source_chunk_ids": [
        "e41a1d643678bd30f5fb493982c34a70"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "releasing Pro-inflammatory cytokines (TNF-\u03b1)",
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "releasing Pro-inflammatory cytokines (IL-6)",
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "releasing Pro-inflammatory cytokines (IL-1\u03b2)",
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "releasing Pro-inflammatory cytokines (MCP-1)",
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "cytokines stimulate the liver, leading to CRP",
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "cytokines stimulate the liver, leading to CRP",
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "cytokines stimulate the liver, leading to CRP",
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "cytokines stimulate the liver, leading to CRP",
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "release of additional mediators (TNF-\u03b1)",
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "release of additional mediators (IL-6)",
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "release of additional mediators (IL-1\u03b2)",
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "release of additional mediators (MCP-1)",
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E17",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "resulting symptoms: FATIGUE",
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E18",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "resulting symptoms: PSYCHOMOTOR SLOWING",
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E19",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "resulting symptoms: ANHEDONIA",
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E20",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "resulting symptoms: COGNITIVE IMPAIRMENT",
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E21",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "neuroinflammation and mood disorders",
      "source_chunk_ids": [
        "c994aff044acef6bbf4aec44d2667a7b"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "disrupt tight junction proteins, leading to increased permeability",
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "disrupt tight junction proteins, leading to increased permeability",
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "disrupt tight junction proteins, leading to increased permeability",
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E13",
      "target_entity_id": "E14",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "permit cytokines to reach the CNS, foster neuroinflammation",
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "SUGGESTS",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.8,
      "evidence": "BBB dysfunction in mood disorders, MDD",
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "SUGGESTS",
      "source_entity_id": "E9",
      "target_entity_id": "E11",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.8,
      "evidence": "BBB dysfunction in mood disorders, BD",
      "source_chunk_ids": [
        "bf26b93421470879825831758b4710fc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Gut dysbiosis leads to systemic inflammation",
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Systemic inflammation drives neuroinflammation",
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "neuroinflammation in depression",
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E11",
      "target_entity_id": "E8",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "LPS activate monocytes",
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E12",
      "target_entity_id": "E8",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.75,
      "evidence": "PGN activate monocytes",
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E13",
      "target_entity_id": "E8",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.75,
      "evidence": "TMAO activate monocytes",
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E14",
      "target_entity_id": "E8",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.75,
      "evidence": "flagellin activate monocytes",
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "monocytes produce cytokines",
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "cytokines lead to systemic inflammation",
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E5",
      "attributes": {
        "action": "disrupts"
      },
      "confidence": 0.8,
      "evidence": "Systemic inflammation disrupt the BBB",
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E6",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.85,
      "evidence": "Systemic inflammation activate microglia",
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E7",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.75,
      "evidence": "Systemic inflammation activate astrocytes",
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "activate microglia drive neuroinflammation",
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "activate astrocytes drive neuroinflammation",
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "action": "impairs"
      },
      "confidence": 0.85,
      "evidence": "Gut dysbiosis leads to impaired gut barrier integrity",
      "source_chunk_ids": [
        "82475fb06e1907c49eadbf65f6fcfaf0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.75,
      "evidence": "LPS activate TLR4 signaling",
      "source_chunk_ids": [
        "f3afbb81afdf28e84adf4bf7d2c9c86d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.7,
      "evidence": "HMGB1 activate TLR4 signaling",
      "source_chunk_ids": [
        "f3afbb81afdf28e84adf4bf7d2c9c86d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.7,
      "evidence": "extracellular ATP activate TLR4 signaling",
      "source_chunk_ids": [
        "f3afbb81afdf28e84adf4bf7d2c9c86d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "initiates"
      },
      "confidence": 0.85,
      "evidence": "TLR4 initiates intracellular cascades involving NF-\u03baB",
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "initiates"
      },
      "confidence": 0.85,
      "evidence": "TLR4 initiates intracellular cascades involving JAK/STAT",
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "action": "initiates"
      },
      "confidence": 0.85,
      "evidence": "TLR4 initiates intracellular cascades involving MAPK pathways",
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "cytokine receptors activated by IL-6, TNF-\u03b1, and IL-1\u03b2",
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "cytokine receptors activated by IL-6, TNF-\u03b1, and IL-1\u03b2",
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "cytokine receptors activated by IL-6, TNF-\u03b1, and IL-1\u03b2",
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E5",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.75,
      "evidence": "cytokine receptors activated by IL-6",
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E5",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.75,
      "evidence": "cytokine receptors activated by TNF-\u03b1",
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E5",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.75,
      "evidence": "cytokine receptors activated by IL-1\u03b2",
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E9",
      "attributes": {
        "action": "mediates"
      },
      "confidence": 0.7,
      "evidence": "NF-\u03baB as key mediators in mood disorders",
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {
        "action": "mediates"
      },
      "confidence": 0.7,
      "evidence": "JAK/STAT as key mediators in mood disorders",
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E9",
      "attributes": {
        "action": "mediates"
      },
      "confidence": 0.7,
      "evidence": "MAPK cascades as key mediators in mood disorders",
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "SUGGESTS",
      "source_entity_id": "E10",
      "target_entity_id": "E9",
      "attributes": {
        "mapping_type": "direct",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "growing evidence implicating TLR4-related pathways in mood disorders",
      "source_chunk_ids": [
        "1a91351f298b65ab235c1ddf2f41d2d2"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "NF-\u03baB activation mediates stress-induced suppression",
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "NF-\u03baB activation mediates depressive-like behavior",
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "IL-6/STAT3 signaling linked to impaired neuroplasticity",
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "MAPK activation enhances glutamate release",
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "MAPK activation enhances ROS generation",
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "promoting excitotoxicity",
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "promoting excitotoxicity",
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "activation results in production of cytokines",
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "activation results in production of cytokines",
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "activation results in production of cytokines",
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "correlates"
      },
      "confidence": 0.75,
      "evidence": "meta-analyses show elevations in MDD",
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E14",
      "attributes": {
        "outcome": "identifies"
      },
      "confidence": 0.7,
      "evidence": "delineating an inflamed depression subgroup",
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E15",
      "attributes": {
        "outcome": "correlates"
      },
      "confidence": 0.7,
      "evidence": "In BD, CRP and TNF-\u03b1 increase",
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E16",
      "attributes": {
        "outcome": "correlates"
      },
      "confidence": 0.7,
      "evidence": "rise in acute phases of psychosis",
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E17",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "linked to severity and treatment resistance",
      "source_chunk_ids": [
        "3fb4c5dd6592d334af4619a02c36664a"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "provides a priming signal for transcriptional upregulation through NF-\u03baB activation",
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "NF-\u03baB activation leads to transcriptional upregulation",
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "inflammasome promotes cleavage of pro-IL-1\u03b2 and pro-IL-18",
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "driving pyroptotic cell death",
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "amplifying inflammatory cascades",
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Preclinical studies show",
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {
        "role": "condition"
      },
      "confidence": 0.85,
      "evidence": "chronic stress enhances NLRP3 activation",
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "enhances"
      },
      "confidence": 0.85,
      "evidence": "chronic stress enhances NLRP3 activation",
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.85,
      "evidence": "leading to increased IL-1\u03b2 release",
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "inhibition of neurogenesis",
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E13",
      "attributes": {
        "outcome": "disrupts"
      },
      "confidence": 0.85,
      "evidence": "disruption of synaptic plasticity",
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E14",
      "attributes": {
        "outcome": "emerges"
      },
      "confidence": 0.85,
      "evidence": "emergence of depressive-like behavior",
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "chronic stress enhances NLRP3 activation",
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "leading to increased IL-1\u03b2 release",
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "inhibition of neurogenesis",
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "disruption of synaptic plasticity",
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "leading to depressive-like behavior",
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "PRODUCES",
      "source_entity_id": "E13",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "leading to depressive-like behavior",
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R19",
      "type": "SUGGESTS",
      "source_entity_id": "E14",
      "target_entity_id": "E15",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.75,
      "evidence": "depressive-like behavior",
      "source_chunk_ids": [
        "8c681ae54deb5036c463be5da5b7a934"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "inhibition of the NLRP3 inflammasome with MCC950",
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "restoring neuroplasticity",
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "behavioral resilience",
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "animal models",
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "animal models",
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "action": "reduces"
      },
      "confidence": 0.85,
      "evidence": "conventional antidepressants reduce NLRP3 activation",
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {
        "action": "reduces"
      },
      "confidence": 0.85,
      "evidence": "reduce IL-1\u03b2 release",
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "reduce NLRP3 activation",
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "experimental models",
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "ACTS_ON",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {
        "action": "enhances"
      },
      "confidence": 0.85,
      "evidence": "enhance synaptic serotonin",
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "ACTS_ON",
      "source_entity_id": "E10",
      "target_entity_id": "E12",
      "attributes": {
        "action": "enhances"
      },
      "confidence": 0.85,
      "evidence": "enhance norepinephrine",
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "promote downstream plasticity adaptations",
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "TREATS",
      "source_entity_id": "E10",
      "target_entity_id": "E14",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.85,
      "evidence": "antidepressant outcomes",
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "ACTS_ON",
      "source_entity_id": "E16",
      "target_entity_id": "E15",
      "attributes": {
        "action": "predicts response"
      },
      "confidence": 0.8,
      "evidence": "CRP predicts response to escitalopram",
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "HAS_CLASS",
      "source_entity_id": "E16",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "SSRI escitalopram",
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "HAS_CLASS",
      "source_entity_id": "E17",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "noradrenergic/dopaminergic options",
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "HAS_CLASS",
      "source_entity_id": "E18",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "bupropion-containing regimens",
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "SUGGESTS",
      "source_entity_id": "E19",
      "target_entity_id": "E21",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "linking to neuroinflammatory processes in mood disorders",
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R19",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E21",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "linking to neuroinflammatory processes in mood disorders",
      "source_chunk_ids": [
        "14e745906f84b217c6931081afeb2cfe"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "hubs include mitochondrial dysfunction",
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "hubs include oxidative stress",
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "hubs include glial activation",
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "hubs include impaired neuroimmune homeostasis",
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "hubs include neurotrophic alterations",
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "hubs include synaptic alterations",
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "hubs include dysregulation of the kynurenine pathway",
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "brain deficits observed in MDD",
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "brain deficits observed in BD",
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "explains clinical dimensions such as fatigue",
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "explains clinical dimensions such as cognitive impairment",
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "explains clinical dimensions such as anhedonia",
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "explains clinical dimensions such as reduced responsiveness",
      "source_chunk_ids": [
        "44436c50c4918369f88d32e8e696bc9e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "meta-analysis by Liu et al. (2015)",
      "source_chunk_ids": [
        "0dc9ba4547cc461a1210b8e6a764d8c3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "associated_with"
      },
      "confidence": 0.85,
      "evidence": "increased oxidative damage markers in mood disorders",
      "source_chunk_ids": [
        "0dc9ba4547cc461a1210b8e6a764d8c3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "SUGGESTS",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "targeting redox balance is therapeutically relevant",
      "source_chunk_ids": [
        "0dc9ba4547cc461a1210b8e6a764d8c3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "NAC supplementation",
      "source_chunk_ids": [
        "0dc9ba4547cc461a1210b8e6a764d8c3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {
        "action": "replenishes"
      },
      "confidence": 0.75,
      "evidence": "replenishes glutathione",
      "source_chunk_ids": [
        "0dc9ba4547cc461a1210b8e6a764d8c3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "improves symptoms",
      "source_chunk_ids": [
        "0dc9ba4547cc461a1210b8e6a764d8c3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "TREATS",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "context": "clinical",
        "supporting_study_ids": [
          "E5"
        ],
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "improves symptoms in mood disorders",
      "source_chunk_ids": [
        "0dc9ba4547cc461a1210b8e6a764d8c3"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "exert antioxidant effects",
      "source_chunk_ids": [
        "cbb9f7601073a2259c0b3640b104e011"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "exert anti-inflammatory effects",
      "source_chunk_ids": [
        "cbb9f7601073a2259c0b3640b104e011"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "enhances bioenergetics",
      "source_chunk_ids": [
        "cbb9f7601073a2259c0b3640b104e011"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "links to fatigue",
      "source_chunk_ids": [
        "cbb9f7601073a2259c0b3640b104e011"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "links to psychomotor slowing",
      "source_chunk_ids": [
        "cbb9f7601073a2259c0b3640b104e011"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "links to poor treatment response",
      "source_chunk_ids": [
        "cbb9f7601073a2259c0b3640b104e011"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "JAK/STAT3 pathway leads to Neuroinflammation \u2191",
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "NF-\u03baB pathway leads to Neuroinflammation \u2191",
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "MAPK pathways lead to Neuroplasticity \u2193",
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "MAPK pathways lead to Glutamatergic dysregulation \u2191",
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "NF-\u03baB pathway leads to Oxidative stress \u2191",
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Neuroinflammation \u2191 leads to Treatment resistance \u2191",
      "source_chunk_ids": [
        "7c65bc31333809f1b21c0047793b67fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "JAK/STAT3, promoting astrocyte reactivity",
      "source_chunk_ids": [
        "5733fc14c1b0b62049161682875cde6c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "JAK/STAT3, promoting pro-inflammatory gene programs",
      "source_chunk_ids": [
        "5733fc14c1b0b62049161682875cde6c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "amplify neuroinflammation, impair neuroplasticity",
      "source_chunk_ids": [
        "5733fc14c1b0b62049161682875cde6c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "amplify neuroinflammation, disrupt glutamatergic homeostasis",
      "source_chunk_ids": [
        "5733fc14c1b0b62049161682875cde6c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "amplify neuroinflammation, increase oxidative/NO stress",
      "source_chunk_ids": [
        "5733fc14c1b0b62049161682875cde6c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "amplify neuroinflammation, contribute to treatment resistance",
      "source_chunk_ids": [
        "5733fc14c1b0b62049161682875cde6c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "contributing to excitotoxicity",
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "excitotoxicity and synaptic pruning",
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "neurogenesis and tissue repair",
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "neurogenesis and tissue repair",
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E11",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "impairs clearance of excitatory neurotransmitters",
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E14",
      "target_entity_id": "E13",
      "attributes": {
        "outcome": "contributes"
      },
      "confidence": 0.8,
      "evidence": "contributes to depressive phenotypes",
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E14",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Yirmiya et al. (2015) reviewed",
      "source_chunk_ids": [
        "768923f74d23fd079c0e8c99c903d1d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "postmortem studies show reduced GFAP+ astrocytic density in depressed patients",
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "reduced GFAP+ astrocytic density",
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "These changes reduce trophic support",
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "impair synaptic homeostasis",
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "amplify excitotoxic cascades",
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "In vivo evidence from TSPO-PET imaging corroborates these findings",
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "elevated"
      },
      "confidence": 0.85,
      "evidence": "showed elevated TSPO binding",
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E10",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "meta-analysis confirmed increased TSPO binding",
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "increased"
      },
      "confidence": 0.85,
      "evidence": "confirmed increased TSPO binding",
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "STUDIES",
      "source_entity_id": "E11",
      "target_entity_id": "E12",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "interventions targeting glial activation",
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "found no reduction in TSPO binding after minocycline",
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "STUDIES",
      "source_entity_id": "E13",
      "target_entity_id": "E14",
      "attributes": {
        "role": "biomarker"
      },
      "confidence": 0.8,
      "evidence": "patients with baseline CRP > 5 mg/L",
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E15",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "demonstrated antidepressant effects",
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "SUGGESTS",
      "source_entity_id": "E7",
      "target_entity_id": "E16",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "glial alterations are central to inflammatory depression",
      "source_chunk_ids": [
        "bddfc21524355593381855ac1776e44c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "kynurenine pathway ... toward kynurenine",
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "action": "diverts"
      },
      "confidence": 0.7,
      "evidence": "IDO ... diverting tryptophan",
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "diverts"
      },
      "confidence": 0.7,
      "evidence": "TDO ... diverting tryptophan",
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "tryptophan from serotonin synthesis",
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "downstream metabolites ... quinolinic acid",
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {
        "action": "agonist"
      },
      "confidence": 0.8,
      "evidence": "quinolinic acid ... a potent NMDA agonist",
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "neurotoxic quinolinic acid",
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E8",
      "attributes": {
        "action": "antagonist"
      },
      "confidence": 0.8,
      "evidence": "kynurenic acid ... NMDA antagonist",
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {
        "action": "modulator"
      },
      "confidence": 0.8,
      "evidence": "kynurenic acid ... \u03b17 nicotinic receptor modulator",
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "kynurenic acid ... exerts neuroprotective effects",
      "source_chunk_ids": [
        "d327296ef03a0b0e0c930c740861f807"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Meta-analyses consistently support",
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Meta-analyses consistently support",
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.85,
      "evidence": "across mood disorders",
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "elevated"
      },
      "confidence": 0.8,
      "evidence": "elevated KYN/TRP ratios",
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "increased"
      },
      "confidence": 0.8,
      "evidence": "increased QA",
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "reduced"
      },
      "confidence": 0.8,
      "evidence": "reduced KYNA",
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.85,
      "evidence": "MDD patients",
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "elevated"
      },
      "confidence": 0.8,
      "evidence": "QA elevations in CSF",
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "contribute to oxidative stress",
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "contribute to oxidative stress",
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "neuronal toxicity",
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "neuronal toxicity",
      "source_chunk_ids": [
        "9f9287a5feee2ff125baa4485e625f3e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "SUGGESTS",
      "source_entity_id": "E4",
      "target_entity_id": "E1",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.85,
      "evidence": "KP alterations are associated with suicidality",
      "source_chunk_ids": [
        "61542ad10d90622c39bc5acfb9ba8397"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Sublette et al. (2011) showed",
      "source_chunk_ids": [
        "61542ad10d90622c39bc5acfb9ba8397"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.8,
      "evidence": "showed increased plasma kynurenine in suicide attempters",
      "source_chunk_ids": [
        "61542ad10d90622c39bc5acfb9ba8397"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Agudelo et al. (2014) demonstrated",
      "source_chunk_ids": [
        "61542ad10d90622c39bc5acfb9ba8397"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "exacerbates"
      },
      "confidence": 0.85,
      "evidence": "obesity and insulin resistance enhance IDO activity",
      "source_chunk_ids": [
        "61542ad10d90622c39bc5acfb9ba8397"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "exacerbates"
      },
      "confidence": 0.85,
      "evidence": "obesity and insulin resistance enhance IDO activity",
      "source_chunk_ids": [
        "61542ad10d90622c39bc5acfb9ba8397"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "enhances"
      },
      "confidence": 0.8,
      "evidence": "enhance IDO activity",
      "source_chunk_ids": [
        "61542ad10d90622c39bc5acfb9ba8397"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "immunometabolic factors exacerbate KP shifts",
      "source_chunk_ids": [
        "61542ad10d90622c39bc5acfb9ba8397"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "immunometabolic factors exacerbate KP shifts",
      "source_chunk_ids": [
        "61542ad10d90622c39bc5acfb9ba8397"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "implicates"
      },
      "confidence": 0.7,
      "evidence": "Evidence from postmortem studies",
      "source_chunk_ids": [
        "3cc7626e1cb2ebc24b6d93900726b33f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "implicates"
      },
      "confidence": 0.7,
      "evidence": "neuroimaging",
      "source_chunk_ids": [
        "3cc7626e1cb2ebc24b6d93900726b33f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "implicates"
      },
      "confidence": 0.7,
      "evidence": "animal models",
      "source_chunk_ids": [
        "3cc7626e1cb2ebc24b6d93900726b33f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "shows increased TSPO binding"
      },
      "confidence": 0.75,
      "evidence": "PET imaging studies show increased TSPO ligand binding",
      "source_chunk_ids": [
        "3cc7626e1cb2ebc24b6d93900726b33f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "shows increased TSPO binding"
      },
      "confidence": 0.75,
      "evidence": "PET imaging studies show increased TSPO ligand binding",
      "source_chunk_ids": [
        "3cc7626e1cb2ebc24b6d93900726b33f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "impairs"
      },
      "confidence": 0.8,
      "evidence": "impaired prefrontal\u2013amygdala connectivity in inflamed depression",
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "involves"
      },
      "confidence": 0.8,
      "evidence": "hippocampus shows strong evidence in major depressive disorder",
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "involves"
      },
      "confidence": 0.8,
      "evidence": "Microglial activation in major depressive disorder",
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "involves"
      },
      "confidence": 0.8,
      "evidence": "astrocyte dysfunction in major depressive disorder",
      "source_chunk_ids": [
        "b03a801bb0c1e8f940e176ef8daf1",
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "downregulates"
      },
      "confidence": 0.8,
      "evidence": "downregulation of neurogenesis in major depressive disorder",
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.8,
      "evidence": "hippocampal neuronal survival is decreased in major depressive disorder",
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "TREATS",
      "source_entity_id": "E9",
      "target_entity_id": "E7",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.7,
      "evidence": "Urolithin B can reduce depressive behavior",
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Urolithin B can restore neuronal function",
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Urolithin B can reduce depressive behavior",
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "involves"
      },
      "confidence": 0.8,
      "evidence": "amygdala involvement in mood disorders",
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E13",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.8,
      "evidence": "increased microglial activation in mood disorders",
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E14",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.8,
      "evidence": "inflammatory cytokine expression in mood disorders",
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E15",
      "attributes": {
        "outcome": "involves"
      },
      "confidence": 0.8,
      "evidence": "Reward circuitry in mood disorders",
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E16",
      "attributes": {
        "outcome": "involves"
      },
      "confidence": 0.8,
      "evidence": "nucleus accumbens/ventral striatum in mood disorders",
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E17",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.8,
      "evidence": "inflammation correlates with blunted reward response",
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E18",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.8,
      "evidence": "inflammation correlates with reduced connectivity",
      "source_chunk_ids": [
        "b03a801bb0cb0c1e8f940e176ef8daf1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.8,
      "evidence": "The insula also shows elevated TSPO binding in PET studies of depression",
      "source_chunk_ids": [
        "418ec92073545e5e7e49070f89353e04"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "altered insular activity during interoceptive and affective tasks in patients with high inflammatory states",
      "source_chunk_ids": [
        "418ec92073545e5e7e49070f89353e04"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "consistent with abnormal salience processing",
      "source_chunk_ids": [
        "418ec92073545e5e7e49070f89353e04"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E13",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "stronger immune responses associated with greater vulnerability",
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E15",
      "target_entity_id": "E16",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "hormonal fluctuations may destabilize neuroimmune balance",
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E17",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "Perimenopause linked to higher rates of depression",
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E18",
      "target_entity_id": "E1",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "estradiol withdrawal can trigger symptoms",
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E19",
      "target_entity_id": "E20",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "anti-inflammatory effects include reduced cytokine production",
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E21",
      "target_entity_id": "E22",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "aging-related immune changes associated with higher depressive burden",
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "SUGGESTS",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.8,
      "evidence": "Perimenopause linked to higher rates of depression",
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "SUGGESTS",
      "source_entity_id": "E4",
      "target_entity_id": "E1",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.75,
      "evidence": "enhances vulnerability to late-life depression",
      "source_chunk_ids": [
        "acff882c625f3f1b9fca55ae8abdfc5c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.75,
      "evidence": "suggests that immune-inflammatory mechanisms contribute to mood disorders",
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "Adjunctive celecoxib has demonstrated",
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "antidepressant efficacy in MDD",
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "antimanic effects in BD",
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TREATS",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "antidepressant efficacy in MDD",
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "supporting_study_ids": [
        "E4"
      ],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "antimanic effects in BD",
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "supporting_study_ids": [
        "E4"
      ],
      "verified": true
    },
    {
      "id": "R7",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "infliximab improved symptoms",
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.75,
      "evidence": "improved symptoms only in patients with elevated baseline inflammation",
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "TREATS",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {
        "context": "clinical",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "infliximab improved symptoms only in patients with elevated baseline inflammation",
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "supporting_study_ids": [
        "E8"
      ],
      "verified": false
    },
    {
      "id": "R10",
      "type": "ACTS_ON",
      "source_entity_id": "E15",
      "target_entity_id": "E13",
      "attributes": {
        "action": "counteracts"
      },
      "confidence": 0.8,
      "evidence": "N-acetylcysteine aim to counteract the oxidative stress",
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "ACTS_ON",
      "source_entity_id": "E15",
      "target_entity_id": "E14",
      "attributes": {
        "action": "counteracts"
      },
      "confidence": 0.8,
      "evidence": "counteract the oxidative stress and bioenergetic dysfunction",
      "source_chunk_ids": [
        "1ccc8481701f6199d56b3a8d2ccaea30"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "link with suicidality",
      "source_chunk_ids": [
        "a0c7331a1f1d55df900d5d2469cddb07"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "link with treatment resistance",
      "source_chunk_ids": [
        "a0c7331a1f1d55df900d5d2469cddb07"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.7,
      "evidence": "showing modest but inconsistent benefits",
      "source_chunk_ids": [
        "a0c7331a1f1d55df900d5d2469cddb07"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "clinical translation of immunomodulatory strategies",
      "source_chunk_ids": [
        "4e545ee27a329f8d3b73c5558da2d6db"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.85,
      "evidence": "failed to outperform placebo at the group level",
      "source_chunk_ids": [
        "4e545ee27a329f8d3b73c5558da2d6db"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.75,
      "evidence": "infliximab produced benefits in patients with CRP > 5 mg/L",
      "source_chunk_ids": [
        "4e545ee27a329f8d3b73c5558da2d6db"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "beneficial effects in MDD",
      "source_chunk_ids": [
        "7b1cfbb0fde4d880e904afbaa3ece060"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.75,
      "evidence": "less consistent findings in BD",
      "source_chunk_ids": [
        "7b1cfbb0fde4d880e904afbaa3ece060"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.7,
      "evidence": "beneficial effects in MDD",
      "source_chunk_ids": [
        "7b1cfbb0fde4d880e904afbaa3ece060"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "no_effect",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "less consistent findings in BD",
      "source_chunk_ids": [
        "7b1cfbb0fde4d880e904afbaa3ece060"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.75,
      "evidence": "robust increases in microglial activation",
      "source_chunk_ids": [
        "7b1cfbb0fde4d880e904afbaa3ece060"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.7,
      "evidence": "modest or null results",
      "source_chunk_ids": [
        "7b1cfbb0fde4d880e904afbaa3ece060"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "leads to 'Emerging therapeutic approaches'",
      "source_chunk_ids": [
        "5d22968f7a6c6c228135d16018264678"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R2",
      "type": "TREATS",
      "source_entity_id": "E10",
      "target_entity_id": "E7",
      "attributes": {
        "context": "therapeutic"
      },
      "confidence": 0.7,
      "evidence": "Anti-TNF\u03b1 (Infliximab) as emerging therapeutic",
      "source_chunk_ids": [
        "5d22968f7a6c6c228135d16018264678"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TREATS",
      "source_entity_id": "E11",
      "target_entity_id": "E7",
      "attributes": {
        "context": "therapeutic"
      },
      "confidence": 0.7,
      "evidence": "COX2-inhibitors (Celecoxib) as emerging therapeutic",
      "source_chunk_ids": [
        "5d22968f7a6c6c228135d16018264678"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TREATS",
      "source_entity_id": "E12",
      "target_entity_id": "E7",
      "attributes": {
        "context": "therapeutic"
      },
      "confidence": 0.7,
      "evidence": "Probiotics as emerging therapeutic",
      "source_chunk_ids": [
        "5d22968f7a6c6c228135d16018264678"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "SUGGESTS",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "anti-inflammatory agents such as COX-2 inhibitors (e.g., celecoxib)",
      "source_chunk_ids": [
        "ed7f14b69369a171658cb05467fdb23d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "SUGGESTS",
      "source_entity_id": "E8",
      "target_entity_id": "E6",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "anti-TNF-\u03b1 treatments (e.g., infliximab)",
      "source_chunk_ids": [
        "ed7f14b69369a171658cb05467fdb23d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "SUGGESTS",
      "source_entity_id": "E9",
      "target_entity_id": "E6",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "probiotic interventions",
      "source_chunk_ids": [
        "ed7f14b69369a171658cb05467fdb23d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "direction": "causes"
      },
      "confidence": 0.8,
      "evidence": "inflammation causes mood disorders",
      "source_chunk_ids": [
        "900a374da5bfda5636d242b8bf9d42cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E3",
      "attributes": {
        "direction": "precipitates"
      },
      "confidence": 0.85,
      "evidence": "immune activation can precipitate depressive symptoms",
      "source_chunk_ids": [
        "900a374da5bfda5636d242b8bf9d42cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E4",
      "attributes": {
        "direction": "accompanies"
      },
      "confidence": 0.7,
      "evidence": "increases in IL-6, accompanied by anhedonia",
      "source_chunk_ids": [
        "900a374da5bfda5636d242b8bf9d42cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E5",
      "attributes": {
        "direction": "accompanies"
      },
      "confidence": 0.7,
      "evidence": "increases in TNF-\u03b1, accompanied by dysphoria",
      "source_chunk_ids": [
        "900a374da5bfda5636d242b8bf9d42cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "direction": "develops"
      },
      "confidence": 0.75,
      "evidence": "depressive symptoms develop depression",
      "source_chunk_ids": [
        "900a374da5bfda5636d242b8bf9d42cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "depression promotes inflammatory activity via HPA-axis dysregulation",
      "source_chunk_ids": [
        "5d848fa6fd4b8ef3419d2d7874846d14"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "depressive symptoms predicting later increases in CRP",
      "source_chunk_ids": [
        "5d848fa6fd4b8ef3419d2d7874846d14"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "depressive symptoms predicting later increases in CRP and IL-6",
      "source_chunk_ids": [
        "5d848fa6fd4b8ef3419d2d7874846d14"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Prospective cohorts demonstrate this reverse pathway",
      "source_chunk_ids": [
        "5d848fa6fd4b8ef3419d2d7874846d14"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "promotes"
      },
      "confidence": 0.7,
      "evidence": "depression itself promotes inflammatory activity",
      "source_chunk_ids": [
        "5d848fa6fd4b8ef3419d2d7874846d14"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.7,
      "evidence": "increases in CRP",
      "source_chunk_ids": [
        "5d848fa6fd4b8ef3419d2d7874846d14"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.7,
      "evidence": "increases in CRP and IL-6",
      "source_chunk_ids": [
        "5d848fa6fd4b8ef3419d2d7874846d14"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "SUGGESTS",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.75,
      "evidence": "Evidence on immune\u2013inflammatory dysregulation in MDD",
      "source_chunk_ids": [
        "8b002f39b5015b8d77dcd80bf739e960"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "immune\u2013inflammatory dysregulation in major depressive disorder",
      "source_chunk_ids": [
        "8b002f39b5015b8d77dcd80bf739e960"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "role of neuroinflammation in major depressive disorder",
      "source_chunk_ids": [
        "8b002f39b5015b8d77dcd80bf739e960"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "peripheral biomarkers",
      "source_chunk_ids": [
        "8b002f39b5015b8d77dcd80bf739e960"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "kynurenine pathway",
      "source_chunk_ids": [
        "8b002f39b5015b8d77dcd80bf739e960"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "neuroimaging",
      "source_chunk_ids": [
        "8b002f39b5015b8d77dcd80bf739e960"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "oxidative stress",
      "source_chunk_ids": [
        "8b002f39b5015b8d77dcd80bf739e960"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "gut\u2013brain axis",
      "source_chunk_ids": [
        "8b002f39b5015b8d77dcd80bf739e960"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E10",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "interventional studies",
      "source_chunk_ids": [
        "8b002f39b5015b8d77dcd80bf739e960"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E17",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "inflammation and neuroinflammation in depression",
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E17",
      "target_entity_id": "E18",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "neuroinflammation linked to impaired neurogenesis",
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E18",
      "target_entity_id": "E19",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "impaired neurogenesis and depressive behavior",
      "source_chunk_ids": [
        "3789fcf3f49bdbfef522a60337a0f56a"
      ],
      "supporting_study_ids": [],
      "verified": true
    }
  ]
}